Study Notes BS Biotechnology at Mohi-ud-Din Islamic University

Get valuable study notes for BS Biotechnology at Mohi-ud-Din Islamic University to excel in your coursework. Helpful tips and key concepts included.pursuing a degree in Biotechnology at Mohi-ud-Din Islamic University can provide you with a solid foundation in the field and prepare you for a successful career in biotechnology. By following the tips outlined in this article and utilizing the study notes provided, you can excel in your academic studies and achieve your educational goals. Good luck in your academic journey!

Study Notes BS Biotechnology at Mohi-ud-Din Islamic University.

INTRODUCTION TO BIOTECHNOLOGY – Complete Study Notes

This comprehensive guide covers the fundamental principles, historical development, core techniques, and applications of biotechnology across medicine, agriculture, industry, and environment. These notes are designed for undergraduate students of biotechnology, life sciences, and related fields.


PART 1: WHAT IS BIOTECHNOLOGY?

1.1 Definition and Scope

Definition: Biotechnology is the application of scientific and engineering principles to the processing of materials by biological agents to provide goods and services. It involves the use of living organisms (microorganisms, plant cells, animal cells) or their components (enzymes) to develop or manufacture useful products.

Key Definitions (Historical):

Year Definition Source
1919 “The use of biological processes for industrial production” Karl Ereky (Hungarian engineer; coined the term)
1980s “Any technique that uses living organisms or their products to make or modify a product, improve plants or animals, or develop microorganisms for specific uses” Office of Technology Assessment (US Congress)
1992 “The integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services” EFB (European Federation of Biotechnology)
Modern “The use of cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet” Biotechnology Innovation Organization (BIO)

1.2 Biotechnology Timeline (Historical Development)

Era Development Significance
6000 BCE Fermentation (beer, wine, bread) First use of microbes (yeast)
4000 BCE Cheese and yogurt production Lactic acid bacteria
2500 BCE Leavened bread (Egypt) Yeast fermentation
500 BCE Moldy soybean curds (China) Early antibiotic use (mold)
1857 Pasteur’s work on fermentation Germ theory; microbial metabolism
1897 Buchner’s cell-free fermentation Enzymes can function outside cells
1914-1918 Acetone-butanol fermentation (Weizmann) Industrial solvents from starch
1928 Fleming discovers penicillin Antibiotic era
1940s Large-scale penicillin production (WWII) Industrial fermentation
1953 Watson and Crick discover DNA structure Molecular biology foundation
1960s Genetic code deciphered Understanding of gene expression
1972 Cohen and Boyer: first recombinant DNA Birth of genetic engineering
1975 Kohler and Milstein: monoclonal antibodies Immunotechnology
1980 First patent for a microorganism (oil-eating bacterium) Patent law for biotech
1982 First recombinant protein (human insulin, Humulin®) First biotech drug (Eli Lilly)
1983 First transgenic plant (tobacco) Plant biotechnology
1988 First PCR machine DNA amplification
1990 First gene therapy trial (ADA-SCID) Gene therapy
1996 Dolly the sheep cloned Cloning (somatic cell nuclear transfer)
2000 Human Genome Project (draft) Genomics era
2003 Human Genome Project completed Complete human genome sequence
2012 CRISPR-Cas9 gene editing Precision genome editing
2019 COVID-19 mRNA vaccines (Pfizer/BioNTech, Moderna) RNA therapeutics

1.3 Color Classification of Biotechnology

Color Field Examples
Red Medical biotechnology Pharmaceuticals, vaccines, gene therapy, diagnostics, regenerative medicine
Green Agricultural biotechnology Genetically modified crops, biofertilizers, biopesticides, plant tissue culture, molecular breeding
White/Gray Industrial biotechnology Enzymes, biofuels, bioplastics, biochemicals, fermentation, biocatalysis
Blue Marine biotechnology Marine-derived drugs, aquaculture, algal biofuels, marine enzymes
Yellow Food biotechnology Probiotics, fermented foods, food enzymes, food safety testing
Gold Bioinformatics DNA sequence analysis, protein structure prediction, computational biology
Black Bioweapons and biosecurity Biological warfare, bioterrorism, biosecurity (often considered negative use)
Purple Patent and legal aspects Intellectual property, biotech law, regulatory affairs

PART 2: CORE TECHNIQUES IN BIOTECHNOLOGY

2.1 DNA Replication and PCR

Polymerase Chain Reaction (PCR):

Component Purpose Typical Concentration/Range
DNA template Target sequence to be amplified 10 pg – 1 μg
Primers (forward and reverse) Flank target sequence; provide 3′-OH for polymerase 0.1-1 μM each
dNTPs Building blocks for new DNA 200 μM each
DNA polymerase (Taq, Pfu, Phusion, Q5) Synthesizes new DNA; Taq from Thermus aquaticus (thermostable) 0.5-2 units (U)
Buffer Optimal pH, ionic strength 1× (manufacturer supplied)
Mg²⁺ (or other divalent cation) Cofactor for DNA polymerase 1.5-3 mM

Thermal Cycling Steps:

Step Temperature Time Purpose
Initial denaturation 94-98°C 2-5 min Fully denature DNA (break H-bonds)
Denaturation 94-98°C 15-30 sec Separate strands
Annealing 50-65°C 15-60 sec Primers bind to complementary sequences (Tm ~5°C below primer melting temperature)
Extension 72°C 1 min per kb (for Taq) Polymerase extends primers
Final extension 72°C 5-10 min Complete incomplete extensions
Cycles 25-40 — Exponential amplification

PCR Variants:

Variant Purpose Modification
RT-PCR Amplify RNA (cDNA intermediate) Reverse transcriptase first (RNA → cDNA)
qPCR (real-time PCR) Quantify DNA or RNA SYBR Green or TaqMan probe (fluorescence monitored each cycle)
Nested PCR Increase specificity Two rounds of PCR (second with internal primers)
Multiplex PCR Amplify multiple targets simultaneously Multiple primer pairs in same reaction
Inverse PCR Amplify unknown flanking sequences Primers oriented outward; circularized template
Colony PCR Screen bacterial colonies for inserts Directly from colonies (omit DNA extraction)

2.2 Gel Electrophoresis

Feature Agarose Gel Electrophoresis Polyacrylamide Gel Electrophoresis (PAGE)
Matrix Agarose (polysaccharide from seaweed) Polyacrylamide (cross-linked acrylamide)
Pore size Large (50-500 nm) Small (10-200 nm)
Resolution Low (distinguishes fragments differing by 100-500 bp) High (distinguishes fragments differing by 1-2 bp)
Range 100 bp – 20+ kb 10 bp – 3 kb (DNA)
Application DNA fragment separation (size estimation); PCR product checking DNA sequencing; protein separation (SDS-PAGE)
Staining Ethidium bromide (EtBr), SYBR Safe, GelRed, methylene blue Silver staining; Coomassie Blue (proteins); SYBR Gold (DNA)

2.3 Restriction Enzymes

Type Recognition Site Cut Requires ATP? Example
Type I Complex (bipartite) Random, distant from recognition site (1,000 bp away) Yes EcoKI, EcoAI
Type II Palindromic (4-8 bp) Within recognition site (specific) No EcoRI, HindIII, BamHI, SmaI
Type III Asymmetric (bipartite) Near recognition site (20-30 bp away) Yes EcoP15I

Examples of Type II Restriction Enzymes (Most Commonly Used):

Enzyme Source Recognition Sequence (5’→3′) Cut Type Overhang
EcoRI E. coli RY13 G↓AATTC Sticky (cohesive) 5′ overhang (AATT)
HindIII Haemophilus influenzae Rd A↓AGCTT Sticky 5′ overhang (AGCT)
BamHI Bacillus amyloliquefaciens H G↓GATCC Sticky 5′ overhang (GATC)
PstI Providencia stuartii CTGCA↓G Sticky 3′ overhang (TGCA)
SmaI Serratia marcescens CCC↓GGG Blunt —
EcoRV E. coli J62-74 GAT↓ATC Blunt —
NotI Nocardia otitidis-caviarum GC↓GGCCGC Sticky 5′ overhang (GGCC) (rare cutter; 8 bp recognition)

2.4 Cloning Vectors

Vector Insert Size Features Use
Plasmid 0.1-10 kb Ori (origin of replication), selectable marker (antibiotic resistance), MCS (multiple cloning site) Gene cloning, expression, subcloning
Bacteriophage λ (lambda) 10-20 kb Cos sites; packaging into phage heads; linear genome Genomic libraries
Cosmid 35-45 kb Plasmid + cos sites (from λ phage) Large inserts (genomic libraries)
BAC (Bacterial Artificial Chromosome) 100-300 kb F-factor based; low copy (1-2 per cell) Genomic libraries, genome projects
YAC (Yeast Artificial Chromosome) 100-2000 kb Telomeres, centromere, ARS (autonomously replicating sequence) Large genomic fragments (human genome project)
Ti plasmid (Agrobacterium) Variable T-DNA (transferred to plant genome); vir genes Plant transformation
Shuttle vector Variable Origin for multiple hosts (E. coli + yeast; E. coli + mammalian) Gene transfer between species
Expression vector Variable Promoter (inducible: lac, tac, T7, tetracycline, arabinose), terminator, ribosome binding site (RBS, Shine-Dalgarno sequence) Protein expression

2.5 DNA Sequencing

Sanger Sequencing (Chain Termination Method):

Component Function
DNA template Target sequence
Primer Initiates synthesis
DNA polymerase Extends
dNTPs (dATP, dGTP, dCTP, dTTP) Chain elongation
ddNTPs (ddATP, ddGTP, ddCTP, ddTTP, each with different fluorescent dye) Chain termination (no 3′-OH)

Principle: Random incorporation of ddNTPs terminates synthesis at different positions → fragments of different lengths; capillary electrophoresis separates fragments by size; laser detects fluorescent dye. Read length: 500-1000 bp.

Next-Generation Sequencing (NGS):

Platform Method Read length Throughput Error type Cost per genome (2024)
Illumina (SBS) Reversible dye terminators; bridge amplification 50-300 bp Very high (terabases) Substitutions (phasing errors) $200-500 (human genome; 30× coverage)
Ion Torrent (PGM, Proton) Semiconductor (pH change from H⁺ release during polymerization) 200-400 bp Medium (gigabases) Indels (homopolymer errors) $1000-2000
Pacific Biosciences (SMRT) Single molecule; real-time; zero-mode waveguides 10-25 kb Low-medium (gigabases) Indels (random errors) $2000-5000
Oxford Nanopore Protein nanopore; current change as DNA passes through 10-1000+ kb Medium (gigabases) Substitutions, indels $1000-2000

2.6 Blotting Techniques

Technique Target Separation Method Probe Application
Southern blot DNA (specific sequence) Agarose gel electrophoresis Labeled DNA (complementary) Gene detection; restriction fragment length polymorphism (RFLP); DNA fingerprinting
Northern blot RNA Agarose gel electrophoresis (denaturing) Labeled DNA (complementary) RNA detection; gene expression; transcript size
Western blot Protein SDS-PAGE (polyacrylamide gel) Antibody (primary + secondary labeled antibody) Protein detection; protein size; post-translational modification analysis

2.7 Protein Expression and Purification

Host Systems for Recombinant Protein Expression:

Host Advantages Disadvantages Examples
E. coli Fast growth; high yield; simple; inexpensive No eukaryotic post-translational modifications; inclusion bodies (insoluble protein aggregates); endotoxins Insulin, growth hormone, many enzymes
S. cerevisiae (yeast) Eukaryotic; some post-translational modifications; GRAS (Generally Recognized As Safe) Over-glycosylation; lower yield than E. coli Hepatitis B vaccine (surface antigen), insulin, growth factors
Pichia pastoris (yeast) High yield; strong inducible promoter (AOX1, methanol); protein secretion Methanol required (fire hazard) Many secreted proteins (enzymes, antigens)
Insect cells (baculovirus) Eukaryotic post-translational modifications; high yield (for some proteins) Viral infection required; more complex Complex mammalian proteins (antibodies, receptors)
CHO cells (mammalian) Human-like post-translational modifications; correct folding Slow growth; expensive; low yield Therapeutic antibodies (Rituximab, Trastuzumab), complex glycoproteins
Plant cells (transgenic plants, plant cell culture) Low cost; scalable; no animal pathogens Low yield (often); longer development time Plant-made pharmaceuticals (PMF) – vaccines, antibodies (e.g., tobacco plants)

Protein Purification Steps:

Step Method Principle
Cell lysis Sonication, French press, bead mill, lysozyme (enzymatic), detergent Break open cells
Clarification Centrifugation; filtration Remove cell debris
Initial capture Ammonium sulfate precipitation; ultrafiltration Concentrate protein; remove some contaminants
Ion exchange chromatography (IEX) Bind protein to charged resin (cation or anion exchange); elute with salt gradient (NaCl) Separate by net charge
Size exclusion chromatography (SEC, gel filtration) Separate by size (molecular weight); larger proteins elute first Remove aggregates; buffer exchange
Hydrophobic interaction chromatography (HIC) Bind protein to hydrophobic resin (high salt); elute with decreasing salt gradient Separate by hydrophobicity
Affinity chromatography Bind protein to specific ligand (antibody, metal ion (Ni²⁺ for His-tag), glutathione (GST tag), protein A (for antibodies)) Highly specific; high purity
Concentration Ultrafiltration (centrifugal concentrator) Concentrate final product

Protein Tags for Affinity Purification:

Tag Sequence/Ligand Elution Application
Polyhistidine (His-tag) 6-10 histidines; binds Ni²⁺-NTA resin Imidazole (10-500 mM) Most common; small tag; mild elution
GST (Glutathione S-transferase) 26 kDa; binds glutathione resin Reduced glutathione (10 mM) High purity; soluble; larger tag
FLAG-tag DYKDDDDK (8 amino acids); binds anti-FLAG antibody EDTA or low pH Small tag; specific elution
Strep-tag WSHPQFEK; binds streptavidin Biotin (or desthiobiotin) High specificity; mild elution
MBP (Maltose Binding Protein) 40 kDa; binds amylose resin Maltose (10 mM) Increases solubility of fusion protein

PART 3: MEDICAL BIOTECHNOLOGY (RED BIOTECHNOLOGY)

3.1 Biopharmaceuticals

Type Examples Production Host Indication
Recombinant proteins Insulin (Humulin®) – 1982 E. coli Diabetes
Human growth hormone (hGH) – 1985 E. coli Growth hormone deficiency
Erythropoietin (EPO, Epogen®) – 1989 CHO cells Anemia (kidney disease, chemotherapy)
Interferons (IFN-α, IFN-β, IFN-γ) E. coli or CHO Viral infections; multiple sclerosis; cancer
Tissue plasminogen activator (tPA, Activase®) CHO cells Acute ischemic stroke; myocardial infarction (clot buster)
Monoclonal antibodies (mAbs) Rituximab (Rituxan®) – 1997 CHO cells Non-Hodgkin lymphoma; rheumatoid arthritis
Trastuzumab (Herceptin®) – 1998 CHO cells HER2-positive breast cancer
Bevacizumab (Avastin®) – 2004 CHO cells Colorectal cancer; lung cancer; glioblastoma
Adalimumab (Humira®) – 2002 (first fully human mAb) CHO cells Rheumatoid arthritis; Crohn’s disease; psoriasis
Pembrolizumab (Keytruda®) – 2014 CHO cells Cancer (PD-1 inhibitor; immunotherapy)
Vaccines Hepatitis B vaccine (Recombivax HB®) – 1986 S. cerevisiae (yeast) Hepatitis B (recombinant surface antigen)
HPV vaccine (Gardasil®) – 2006 S. cerevisiae Human papillomavirus (cervical cancer prevention)
COVID-19 mRNA vaccines (Comirnaty® – Pfizer/BioNTech; Spikevax® – Moderna) – 2020 In vitro transcription (cell-free) SARS-CoV-2
COVID-19 viral vector vaccines (AZD1222 – AstraZeneca; Ad26.COV2.S – Johnson & Johnson) – 2020 HEK293 cells (adenovirus vector) SARS-CoV-2
Gene therapy Luxturna® (RPE65 mutation – inherited blindness) – 2017 AAV2 vector (recombinant virus) Leber congenital amaurosis (RPE65 biallelic mutation)
Zolgensma® (SMN1 gene for spinal muscular atrophy) – 2019 AAV9 vector Spinal muscular atrophy (SMA type 1)
Strimvelis® (ADA-SCID) – 2016 Retrovirus (ex vivo, autologous CD34⁺ cells) Adenosine deaminase deficiency (ADA-SCID)
Cell therapy CAR-T cells (Kymriah® – tisagenlecleucel, Yescarta® – axicabtagene ciloleucel) – 2017 Patient T cells (ex vivo; lentivirus or retrovirus transduction) B-cell acute lymphoblastic leukemia; B-cell lymphomas

3.2 Gene Therapy Approaches

Approach Description Vector Examples
Ex vivo Cells removed from patient, modified in lab, returned to patient Retrovirus, lentivirus (integrating), or CRISPR (non-viral) ADA-SCID (Strimvelis®); sickle cell disease; beta-thalassemia; CAR-T cells
In vivo Vector injected directly into patient Adeno-associated virus (AAV; non-integrating), adenovirus (transient), lipid nanoparticles (mRNA) Luxturna® (AAV, RPE65), Zolgensma® (AAV, SMN1), COVID-19 mRNA vaccines (LNP, not gene therapy but RNA therapeutics)

3.3 CRISPR-Cas9 Gene Editing

Component Function Source
Cas9 Endonuclease (cuts DNA); creates double-strand break (DSB) Streptococcus pyogenes (most common)
guide RNA (gRNA) Single guide RNA (sgRNA) – fusion of CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA) Synthetic (designed complementary to target)
Protospacer adjacent motif (PAM) Short sequence (NGG for SpCas9) adjacent to target; required for Cas9 recognition —

Repair Pathways:

Pathway Mechanism Error-prone? Outcome Application
Non-homologous end joining (NHEJ) Joins broken ends directly; small insertions or deletions (indels) Yes (error-prone) Gene knockout (frameshift) Disrupt gene function
Homology-directed repair (HDR) Uses homologous DNA template (donor) for precise repair No (precise, if donor template provided) Gene correction; gene insertion (knock-in) Correct mutation; insert transgene

PART 4: AGRICULTURAL BIOTECHNOLOGY (GREEN BIOTECHNOLOGY)

4.1 Genetically Modified (GM) Crops

Trait Gene(s) Gene Source Crop(s) Effect
Herbicide resistance (glyphosate) cp4 epsps (EPSP synthase) Agrobacterium sp. CP4 Soybean, corn, canola, cotton, sugar beet, alfalfa Tolerant to glyphosate (Roundup®); spray weeds without killing crop
Herbicide resistance (glufosinate) pat or bar (phosphinothricin acetyltransferase) Streptomyces hygroscopicus (pat), S. viridochromogenes (bar) Corn, soybean, canola, cotton, rice Tolerant to glufosinate (Liberty®, Basta®)
Insect resistance (Bt crops) cry1Ab, cry1Ac, cry1F, cry2Ab, cry3Bb, etc. (Cry toxins) Bacillus thuringiensis (soil bacterium) Corn (Bt corn), cotton (Bt cotton), soybean, eggplant (Bt brinjal) Produces insecticidal protein (Cry toxin); effective against Lepidoptera (caterpillars), Coleoptera (beetles), Diptera (flies)
Virus resistance Coat protein (CP) gene Virus (e.g., Papaya ringspot virus, PRSV) Papaya (Rainbow, SunUp); squash; potato Cross-protection (RNA interference; gene silencing)
Delayed ripening Antisense PG (polygalacturonase) or ACC synthase Tomato Flavr Savr® tomato (1994; discontinued) Slows softening; longer shelf life
Golden Rice (β-carotene) psy (phytoene synthase) from daffodil (Narcissus pseudonarcissus) or maize (Zea mays); crtI (phytoene desaturase) from Pantoea ananatis (bacterium) Rice Golden Rice (GR2 – developed 2005) Produces β-carotene (provitamin A); address vitamin A deficiency (VAD) in developing countries
Enhanced iron and zinc Ferritin (soybean), nicotianamine synthase (NAS), ferritin + NAS Multiple sources Rice (multi-biofortified) Increased iron and zinc content

4.2 Plant Transformation Methods

Method Principle Host Efficiency Transgene Integration Advantages Disadvantages
Agrobacterium tumefaciens Natural genetic engineer (Ti plasmid); T-DNA transferred to plant genome Dicots (most); some monocots (wheat, maize, rice with modifications) High (for dicots) Stable (integrated) Simple; low copy number; stable integration; precise T-DNA borders Limited to susceptible species (most monocots less susceptible; requires virulence gene induction with acetosyringone)
Biolistic (gene gun) DNA-coated gold or tungsten particles accelerated into plant cells Wide range (monocots, dicots) Low-moderate Stable (integrated) No host range limitation; can transform multiple copies; can transform organelles (chloroplasts) Multiple copy insertions (gene silencing); transgene rearrangements; expensive
Protoplast transformation (PEG, electroporation) Chemical (PEG) or electrical (electroporation) uptake of DNA into protoplasts (cell wall removed) Wide range Low-moderate Stable (integrated) Direct DNA delivery; can be used for transient expression Protoplast isolation required; regeneration difficult for many species; low efficiency

4.3 Molecular Markers and Marker-Assisted Selection (MAS)

Marker Type Basis Detection Method Polymorphism Advantages Disadvantages
RFLP (Restriction Fragment Length Polymorphism) Restriction site variation Southern blot (restriction digest + probe hybridization) Codominant (can distinguish heterozygotes and homozygotes) Highly reproducible; codominant Slow; labor-intensive; large DNA required; radioactive probes (historically)
RAPD (Random Amplified Polymorphic DNA) Arbitrary primers (10 bp) amplify random genomic regions PCR + gel electrophoresis Dominant (cannot distinguish heterozygotes and homozygotes) Fast; no sequence information needed Low reproducibility; dominant markers
SSR (Simple Sequence Repeat, microsatellite) Tandem repeats (2-6 bp); variation in repeat number PCR + gel electrophoresis or capillary electrophoresis Codominant Highly polymorphic; reproducible Development requires sequence information (primer design)
AFLP (Amplified Fragment Length Polymorphism) Restriction digest + adapter ligation + selective PCR PCR + gel electrophoresis Dominant (mostly) Highly reproducible; no sequence information needed Technically demanding; dominant (mostly)
SNP (Single Nucleotide Polymorphism) Single base pair changes Microarray; PCR (allele-specific); genotyping-by-sequencing (GBS); KASP assay Codominant Most abundant; high throughput; automatable Requires sequence information; SNP discovery needed initially

PART 5: INDUSTRIAL BIOTECHNOLOGY (WHITE BIOTECHNOLOGY)

5.1 Industrial Enzymes

Enzyme Source (microbial) Reaction Industrial Application
Protease (alkaline) Bacillus licheniformis, B. subtilis, B. amyloliquefaciens Hydrolyzes peptide bonds Detergents (removes protein stains), leather processing (unhairing), food (meat tenderizing), silver recovery (photographic film)
Amylase (α-amylase) Bacillus licheniformis, Aspergillus oryzae Hydrolyzes α(1→4) bonds in starch (endo-amylase) Starch liquefaction (ethanol production), desizing textiles, detergents, baking (bread softening)
Glucoamylase (amyloglucosidase) Aspergillus niger, Rhizopus oryzae Hydrolyzes α(1→4) and α(1→6) from non-reducing end (exo) Starch saccharification (glucose syrup)
Cellulase Trichoderma reesei, Aspergillus niger Hydrolyzes cellulose to glucose (β(1→4) linkages) Cellulosic ethanol; textile finishing (stonewashed jeans); detergents; animal feed
Lipase Candida antarctica, Thermomyces lanuginosus, Aspergillus niger Hydrolyzes triglycerides → glycerol + fatty acids; also catalyzes esterification, transesterification Detergents (removes oil stains); biodiesel (transesterification); dairy (flavor development, cheese ripening); baking; pulp and paper
Laccase Trametes versicolor (white-rot fungus), Aspergillus, Myceliophthora Oxidation of phenols, aromatic amines (O₂ as electron acceptor) Pulp bleaching (paper industry); textile dye decolorization; bioremediation (lignin degradation)
Phytase Aspergillus niger, E. coli, Trichoderma reesei Hydrolyzes phytate (inositol hexaphosphate) to phosphate Animal feed (reduces phosphate pollution; improves phosphorus availability to monogastric animals)
Pectinase Aspergillus niger Hydrolyzes pectin (α(1→4) galacturonic acid) Fruit juice clarification (reduces viscosity); wine making; textile degumming (ramie, flax)

5.2 Biofuels

Biofuel Feedstock Process Microorganism/Enzyme Yield Advantages Disadvantages
First-generation ethanol Corn (US), sugarcane (Brazil), wheat (EU), sugar beet, sorghum Fermentation (sugar → ethanol) Saccharomyces cerevisiae (yeast) – glucose fermentation (Embden-Meyerhof-Parnas pathway; glycolysis) 2.5-3.5 gallons/bushel corn; 80-100 L/ton sugarcane Well-established technology; high yield (from sugar/starch) Food vs. fuel; land use change (indirect land use change, ILUC); water consumption; net energy balance questionable (for corn ethanol)
Second-generation ethanol (cellulosic) Lignocellulosic biomass (corn stover, wheat straw, rice straw, sugarcane bagasse, wood chips, switchgrass) Pretreatment (dilute acid, steam explosion, AFEX) → hydrolysis (cellulases, hemicellulases) → fermentation (hexoses and pentoses) Engineered S. cerevisiae (xylose-fermenting); Zymomonas mobilis; Clostridium thermocellum (consolidated bioprocessing, CBP) 50-100 gallons/ton biomass No food competition; uses waste biomass; higher net energy balance High enzyme cost; pretreatment inhibitors (furfural, HMF, acetic acid, phenolics); pentose fermentation inefficient (engineered strains still lower yield than hexose)
Biodiesel Vegetable oils (soybean, rapeseed, palm, sunflower), animal fats, used cooking oil Transesterification (triglycerides + methanol → biodiesel (FAME) + glycerol) Chemical catalyst (NaOH, KOH) or enzyme (lipase, from Candida antarctica, Thermomyces lanuginosus) 1000 L oil → 1000 L biodiesel + 100 L glycerol Renewable; biodegradable; lower emissions (CO, hydrocarbons, particulate matter, NOx slightly higher); lubricity (adds lubricity to diesel fuel) Feedstock cost; glycerol byproduct (low value); cold flow properties (poor at low temperatures); NOx emissions (slightly higher than petroleum diesel)
Biogas (methane) Organic waste (manure, agricultural residue, food waste, sewage sludge) Anaerobic digestion (hydrolysis → acidogenesis → acetogenesis → methanogenesis) Microbial consortia (hydrolytic bacteria, acidogenic bacteria, acetogenic bacteria, methanogenic archaea) 0.5-1 m³ biogas/kg volatile solids (VS) (60-70% CH₄, 30-40% CO₂, trace H₂S, NH₃) Waste treatment + energy; versatile feedstock Low energy density (biogas requires purification to biomethane for vehicle fuel); impurities (H₂S corrosive; must be removed); slow process
Biobutanol (ABE fermentation) Starch, sugar, lignocellulosic biomass (after hydrolysis) Acetone-Butanol-Ethanol (ABE) fermentation Clostridium acetobutylicum, C. beijerinckii, C. saccharoperbutylacetonicum 0.25-0.35 g butanol/g glucose Higher energy density (29.2 MJ/L vs. ethanol 21.2 MJ/L); less volatile; less hygroscopic; can use existing pipelines Low yield; product inhibition (butanol toxicity to Clostridium at ~15 g/L); strain degeneration (loss of solventogenesis after subculture)

5.3 Bioplastics

Type Monomer Microorganism Feedstock Properties Applications Biodegradability
PHB (Poly-3-hydroxybutyrate) 3-hydroxybutyrate Cupriavidus necator (formerly Ralstonia eutropha), recombinant E. coli Glucose, fructose, plant oils (bacterial fermentation) Brittle; stiff; high crystallinity (similar to polypropylene) Packaging; compostable bags; single-use items Biodegradable (soil, marine, compost)
PHBV (Copolymer with 3-hydroxyvalerate) 3-hydroxybutyrate + 3-hydroxyvalerate C. necator (with propionate as co-substrate) Glucose + propionate More flexible; less crystalline than PHB Films; bottles; medical devices (sutures, scaffolds) Biodegradable
PLA (Polylactic acid) Lactic acid (from starch fermentation) Chemical polymerization (not microbial; lactic acid produced by Lactobacillus, then chemically polymerized) Corn starch, sugarcane, cassava Biocompatible; transparent; similar to PET (polyethylene terephthalate) 3D printing filament; food packaging; disposable tableware; sutures; drug delivery Biodegradable (industrial composting; slow in soil)
PCL (Polycaprolactone) ε-caprolactone (chemical synthesis) Chemical polymerization

 

Microbiology – Comprehensive Study Notes

These notes cover the fundamental principles of microbiology, including the history of microbiology, microbial cell structure, classification, metabolism, growth, control, genetics, and applied microbiology. Suitable for undergraduate students in biology, microbiology, biotechnology, and related fields.


Part 1: Foundations of Microbiology

1.1 What is Microbiology?

Microbiology is the study of microorganisms—living entities that are too small to be seen with the naked eye. These include bacteria, archaea, fungi (yeasts and molds), protozoa, algae, and viruses. Microorganisms are found everywhere: in soil, water, air, on and inside plants and animals, and even in extreme environments such as hot springs, deep-sea vents, and the upper atmosphere.

Taxonomic Groups in Microbiology:

Group Cell Type Examples Key Characteristics
Bacteria Prokaryotic Escherichia coli, Bacillus subtilis, Staphylococcus aureus Peptidoglycan cell wall; binary fission
Archaea Prokaryotic Methanogens, Halophiles, Thermophiles Unique membrane lipids; no peptidoglycan; extremophiles
Fungi Eukaryotic Saccharomyces cerevisiae (yeast), Aspergillus niger (mold), Agaricus bisporus (mushroom) Chitin cell walls; heterotrophic; hyphae (filamentous)
Protozoa Eukaryotic Amoeba, Paramecium, Plasmodium (malaria) Unicellular, motile (flagella, cilia, pseudopodia); heterotrophic
Algae Eukaryotic Chlamydomonas, Spirogyra, Diatoms Photosynthetic; diverse pigments; cellulose cell walls
Viruses Acellular HIV, influenza virus, bacteriophage T4 Obligate intracellular parasites; protein coat + nucleic acid
Prions Proteinaceous PrPᵀⁱⁿᵈ (scrapie, CJD) Infectious protein; no nucleic acid; causes spongiform encephalopathies

1.2 History of Microbiology

Year Scientist Contribution
1665 Robert Hooke Observed cells in cork (first observation of cells)
1674 Antonie van Leeuwenhoek First observation of bacteria (“animalcules”) using single-lens microscope
1796 Edward Jenner Developed first vaccine (smallpox using cowpox)
1857 Louis Pasteur Disproved spontaneous generation; developed pasteurization; developed rabies vaccine; discovered fermentation
1876 Robert Koch Demonstrated that Bacillus anthracis causes anthrax; developed Koch’s postulates
1884 Hans Christian Gram Developed Gram staining technique (differentiates bacteria by cell wall composition)
1892 Dmitri Ivanovsky Discovered viruses (tobacco mosaic virus)
1928 Alexander Fleming Discovered penicillin (first antibiotic)
1944 Avery, MacLeod, McCarty Demonstrated DNA is the genetic material (transformation experiment)
1977 Carl Woese Discovered Archaea (third domain of life) using rRNA sequencing

1.3 Koch’s Postulates

Koch’s postulates are four criteria used to establish that a specific microorganism causes a specific disease:

  1. The microorganism must be present in every case of the disease but absent from healthy individuals

  2. The microorganism must be isolated from the diseased host and grown in pure culture

  3. The cultured microorganism must cause the same disease when inoculated into a healthy host

  4. The same microorganism must be re-isolated from the experimentally infected host

Exceptions: Some pathogens cannot be cultured (viruses, Mycobacterium leprae), some cause disease only in specific hosts, some cause multiple diseases, some are present in healthy carriers.

1.4 Spontaneous Generation Debate

The theory of spontaneous generation held that life arises spontaneously from non-living matter (e.g., maggots from meat, mice from dirty hay). Louis Pasteur definitively disproved spontaneous generation using swan-neck flasks, demonstrating that life arises only from pre-existing life (biogenesis).


Part 2: Microbial Cell Structure

2.1 Prokaryotic vs. Eukaryotic Cells

Feature Prokaryotes (Bacteria, Archaea) Eukaryotes (Fungi, Protozoa, Algae)
Nucleus No membrane-bound nucleus Membrane-bound nucleus (with nuclear envelope)
Organelles No membrane-bound organelles (except some Archaea have membrane-bound compartments?) Membrane-bound organelles (mitochondria, ER, Golgi, lysosomes, chloroplasts in algae)
Cell wall Peptidoglycan (bacteria); pseudopeptidoglycan or other polymers (Archaea) Cellulose (algae, plants), chitin (fungi), or absent (protozoa)
Ribosomes 70S 80S (cytoplasm); 70S in mitochondria/chloroplasts
DNA structure Single circular chromosome; plasmids Multiple linear chromosomes
Histones Histone-like proteins (not true histones in bacteria; Archaea have histones similar to eukaryotes) True histones
Reproduction Binary fission (asexual) Mitosis and meiosis (sexual and asexual)
Flagella structure Made of flagellin (hollow filament) Made of microtubules (9+2 arrangement) – microtubules not present in prokaryotic flagella

2.2 Bacterial Cell Structure

General Structure of a Bacterial Cell:

text
┌─────────────────────────────────────────────────────────────┐
│  Capsule (polysaccharide layer; virulence, attachment)      │
│    ┌─────────────────────────────────────────────────────┐  │
│    │  Cell Wall (peptidoglycan) – shape & protection     │  │
│    │    ┌─────────────────────────────────────────────┐  │  │
│    │    │  Cell Membrane (phospholipid bilayer)       │  │  │
│    │    │    ┌─────────────────────────────────────┐  │  │  │
│    │    │    │ Cytoplasm (ribosomes, nucleoid,     │  │  │  │
│    │    │    │ plasmids, inclusions)               │  │  │  │
│    │    │    └─────────────────────────────────────┘  │  │  │
│    │    └─────────────────────────────────────────────┘  │  │
│    └─────────────────────────────────────────────────────┘  │
└─────────────────────────────────────────────────────────────┘
         ↑
    Flagella (motility; made of flagellin; basal body, hook, filament)
Structure Composition Function
Cell membrane Phospholipid bilayer + proteins Selective permeability; respiration; transport
Cell wall Peptidoglycan (NAG-NAG cross-linked with peptide bridges) Structural integrity; shape; prevents osmotic lysis; target of penicillin (inhibits transpeptidase)
Capsule (glycocalyx) Polysaccharide (or polypeptide in some) Adhesion; protection from phagocytosis; biofilm formation
Flagella Flagellin (protein filament) Motility (chemotaxis, phototaxis)
Pili (fimbriae) Pilin (protein) Attachment (fimbriae); conjugation (sex pili – transfer of plasmids)
Nucleoid Circular DNA Genetic information
Plasmids Extrachromosomal circular DNA Antibiotic resistance, virulence factors, metabolic capabilities
Ribosomes rRNA + protein (70S) Protein synthesis
Endospores Keratin-like coat (in some Gram+ bacteria: Bacillus, Clostridium) Survival under extreme conditions (heat, radiation, chemicals, desiccation)

Gram-Positive vs. Gram-Negative Cell Walls:

Feature Gram-Positive Gram-Negative
Peptidoglycan thickness Thick (20-80 nm) Thin (2-7 nm)
Teichoic acids Present Absent
Lipopolysaccharide (LPS) Absent Present (endotoxin – Lipid A)
Outer membrane No Yes
Periplasmic space Narrow Wide
Gram stain result Purple Pink/red
Susceptibility to lysozyme High (digests peptidoglycan) Low (outer membrane blocks lysozyme)
Susceptibility to penicillin High (targets peptidoglycan synthesis) Moderate (outer membrane limits penetration)

Lipopolysaccharide (LPS):

  • Lipid A (endotoxin – causes fever, inflammation, septic shock)

  • Core polysaccharide

  • O-antigen (O-polysaccharide) – antigenic variability (used for serotyping e.g., E. coli O157:H7)

Flagella Arrangements:

Arrangement Description Example
Monotrichous Single flagellum at one pole Vibrio cholerae
Lophotrichous Tuft of flagella at one or both poles Pseudomonas fluorescens
Amphitrichous Single flagellum at both poles Alcaligenes faecalis
Peritrichous Flagella distributed over entire cell Escherichia coli, Bacillus subtilis

2.3 Bacterial Shapes and Arrangements

Shape Term Arrangements Examples
Spherical Cocci (sing. coccus) Single, pairs (diplococci), chains (streptococci), clusters (staphylococci), tetrads, sarcinae (cubical packets of 8) Staphylococcus aureus, Streptococcus pyogenes
Rod-shaped Bacilli (sing. bacillus) Single, chains (streptobacilli), palisades (side-by-side) Escherichia coli, Bacillus anthracis
Spiral Spirilla (rigid), Spirochetes (flexible) Single Spirillum volutans (spirillum), Treponema pallidum (spirochete – syphilis)
Comma-shaped Vibrio Single Vibrio cholerae (cholera)
Pleomorphic Variable shape Single Mycoplasma (lack cell wall)

2.4 Endospores

Endospores are highly resistant, dormant structures formed by some Gram-positive bacteria (Bacillus, Clostridium, Sporosarcina).

Stages of Sporulation (Endospore Formation):

  1. Vegetative cell → DNA replicates; septum forms near one pole

  2. Forespore engulfed by mother cell (double membrane)

  3. Cortex forms (modified peptidoglycan)

  4. Coat proteins deposited (keratin-like)

  5. Spore matures; mother cell lyses → free endospore

Resistance Properties:

  • Heat resistance (up to 120°C – autoclaving required for sterilization)

  • Resistant to UV radiation, desiccation, chemicals (ethanol, disinfectants)

  • Contains dipicolinic acid (DPA) – stabilizes DNA and proteins

  • Calcium chelation contributes to heat resistance

Germination: Return to vegetative state when conditions become favorable (activation by heat, nutrients).

Examples: Bacillus anthracis (anthrax), Clostridium tetani (tetanus), Clostridium botulinum (botulism), Clostridium perfringens (gas gangrene, food poisoning).


Part 3: Microbial Growth and Nutrition

3.1 Microbial Growth Requirements

Requirement Description Classes Based on Requirement
Carbon source Building block for organic molecules Autotroph (CO₂), Heterotroph (organic carbon)
Energy source ATP production Phototroph (light), Chemotroph (chemical compounds)
Electron source Reducing power (NADH, NADPH) Lithotroph (inorganic), Organotroph (organic)
Oxygen For respiration or toxicity Obligate aerobe, Microaerophile, Facultative anaerobe, Aerotolerant anaerobe, Obligate anaerobe
Nitrogen Amino acids, nucleotides N₂ fixation (diazotrophs), NH₄⁺, NO₃⁻, organic N
Phosphorus ATP, nucleic acids, phospholipids PO₄³⁻
Sulfur Amino acids (cysteine, methionine), cofactors SO₄²⁻, H₂S, organic S
Trace elements Enzyme cofactors Fe, Mg, Mn, Zn, Cu, Co, Mo, Ni
Growth factors Organic compounds required for growth Vitamins, amino acids, purines, pyrimidines (auxotrophs require these; prototrophs synthesize)
Temperature Enzyme activity, membrane fluidity Psychrophile, Mesophile, Thermophile, Hyperthermophile
pH Proton gradient, enzyme stability Acidophile, Neutrophile, Alkaliphile
Osmotic pressure Water availability Halophile (requires salt), Halotolerant (tolerates salt), Osmophile (high sugar)

3.2 Oxygen Classification

Class Oxygen Requirement Catalase Superoxide Dismutase (SOD) Examples
Obligate aerobe Required Yes Yes Bacillus subtilis, Pseudomonas aeruginosa
Microaerophile Required (low O₂ 2-10%) Yes (but low activity) Yes Campylobacter jejuni, Helicobacter pylori
Facultative anaerobe Grows with or without O₂ Yes Yes Escherichia coli, Staphylococcus aureus
Aerotolerant anaerobe Does not use O₂; grows in presence (tolerates) No (or low) Yes (or low) Streptococcus pyogenes (lactic acid bacteria)
Obligate anaerobe Killed by O₂ No No Clostridium botulinum, Bacteroides fragilis

Reactive Oxygen Species (ROS) and Detoxifying Enzymes:

ROS Formation Toxic effect Enzyme Reaction
Superoxide radical (O₂⁻) Incomplete reduction of O₂ Damages Fe-S clusters Superoxide dismutase (SOD) 2O₂⁻ + 2H⁺ → H₂O₂ + O₂
Hydrogen peroxide (H₂O₂) SOD reaction; oxidases Oxidizes thiols; forms OH• Catalase (peroxidase) 2H₂O₂ → 2H₂O + O₂ (catalase); H₂O₂ + 2H⁺ + 2e⁻ → 2H₂O (peroxidase, using NADH)
Hydroxyl radical (OH•) Fenton reaction (Fe²⁺ + H₂O₂) Damages DNA, lipids, proteins No enzymatic defense Requires prevention (scavengers, repair systems)

3.3 Temperature Classification

Class Temperature Range (°C) Optimum (°C) Examples
Psychrophile -5 to 20 10-15 Polaromonas vacuolata (Antarctic), Psychrobacter
Psychrotroph 0 to 35 20-30 Pseudomonas fluorescens (spoils refrigerated food)
Mesophile 15 to 45 30-40 Escherichia coli (37°C), Bacillus subtilis, human pathogens
Thermophile 40 to 80 50-65 Geobacillus stearothermophilus (used for autoclave testing – biological indicator)
Hyperthermophile 65 to 120 80-110 Pyrolobus fumarii (113°C optimal), Thermus aquaticus (source of Taq polymerase for PCR)

3.4 pH Classification

Class Optimal pH Examples
Acidophile 0.5-3.0 Acidithiobacillus ferrooxidans (oxidizes Fe²⁺, S⁰; used in bioleaching of copper), Sulfolobus (Archaea)
Neutrophile 6.5-7.5 Most human pathogens (E. coli, Staphylococcus aureus), many environmental bacteria
Alkaliphile 8.5-11.0 Bacillus alkalophilus (produces alkaline proteases used in detergents)

3.5 Bacterial Growth Curve

When bacteria are inoculated into fresh medium, they exhibit a predictable growth pattern with four distinct phases:

Phase Description Characteristics
Lag Phase Adaptation to new environment; cells synthesize necessary enzymes and metabolites No increase in cell number; increase in cell size; metabolic activity high; length depends on nutrient richness and inoculum condition
Log (Exponential) Phase Cells divide at constant maximum rate Balanced growth; cell number doubles every generation (generation time or doubling time); cells most uniform in size/composition; most sensitive to antibiotics and other stresses; growth rate depends on nutrient availability and environmental conditions
Stationary Phase Growth rate = death rate; cell number constant Nutrient depletion; waste accumulation; secondary metabolites produced (antibiotics, toxins, pigments); endospore formation begins in some species; stress responses activated
Death (Decline) Phase Death rate exceeds growth rate Cell number decreases exponentially; cell lysis; some cells persist (persister cells) or form endospores

Generation Time (Doubling Time): Time required for population to double during log phase.

Mathematical Expression of Exponential Growth:

  • N = N₀ × 2ⁿ (where n = number of generations)

  • N = N₀ × e^(μt) (where μ = specific growth rate constant per hour)

Calculations:

  • n = (log N – log N₀) / log 2 = 3.322 × (log N – log N₀)

  • Generation time (g) = t / n (where t = time of exponential growth)

3.6 Measurement of Microbial Growth

Method Principle Application Advantages Disadvantages
Direct microscopic count Count cells in defined volume (Petroff-Hausser counting chamber) Rapid estimation Simple, fast; observes morphology Cannot distinguish live/dead; requires high cell density (>10⁷ cells/mL); motility affects accuracy
Viable plate count Count colony-forming units (CFU) after plating dilutions Viable cell count Measures only live cells; sensitive (detects low numbers) Time-consuming (24-48h incubation); assumes each colony from single cell (may not hold for chains/clumps)
Turbidimetric (OD) Measure light scattering at 600 nm (OD₆₀₀) Rapid growth estimation Fast, non-destructive Measures total cells (live + dead); requires standard curve for calibration; nonlinear at high cell density
Dry weight Filter and weigh biomass Filamentous organisms, biomass estimation Direct measure of biomass Destructive; low sensitivity; time-consuming
Flow cytometry Light scattering and fluorescence of individual cells Cell counting, viability (dye exclusion), cell sorting Fast (10⁴-10⁵ cells/sec); multiparameter; distinguishes live/dead Expensive equipment; requires trained operator

Viable Plate Count Methods:

  • Spread plate: Sample spread on surface of agar plate (requires absorbent surface)

  • Pour plate: Sample mixed with molten agar then poured into plate (thermally sensitive microbes may be damaged)

  • Membrane filtration: Sample filtered through membrane; membrane placed on agar (for low cell density samples like water analysis)


Part 4: Microbial Metabolism

4.1 Central Carbon Metabolism Pathways

Pathway Input Output ATP Yield (per glucose) Location Organisms
Glycolysis (EMP pathway) Glucose 2 Pyruvate, 2 ATP (net), 2 NADH 2 ATP (substrate-level phosphorylation) + 2 NADH (→ up to 6 ATP via ETC) Cytoplasm Most organisms (bacteria, archaea, eukaryotes)
Pentose Phosphate Pathway (PPP) Glucose-6-P NADPH, ribose-5-P (nucleotide synthesis), erythrose-4-P (aromatic amino acids) No ATP; generates NADPH and pentose sugars Cytoplasm Many bacteria, eukaryotes
Entner-Doudoroff (ED) pathway Glucose-6-P 2 Pyruvate, 1 ATP, 1 NADPH, 1 NADH 1 ATP (net) per glucose Cytoplasm Pseudomonas, Zymomonas mobilis, some Archaea
TCA (Krebs) cycle Acetyl-CoA (from pyruvate) 3 NADH, 1 FADH₂, 1 GTP (ATP), 2 CO₂ ~10 ATP (via oxidative phosphorylation) Cytoplasm (prokaryotes); mitochondrial matrix (eukaryotes) Aerobic organisms
Fermentation Pyruvate (or other organic acids) Lactic acid, ethanol, CO₂, butyrate, etc. 2 ATP (substrate-level – from glycolysis) Cytoplasm Anaerobic or facultative organisms

Electron Carriers and Their Roles:

  • NADH: Reduced by catabolic pathways (glycolysis, TCA) → feeds electrons into ETC for oxidative phosphorylation (generates ~2.5-3 ATP per NADH in eukaryotes; variable in prokaryotes)

  • NADPH: Reduced by PPP, some TCA reactions → used in anabolic reactions (biosynthesis, lipid synthesis, detoxification of ROS)

  • FADH₂: Reduced in TCA cycle (succinate dehydrogenase) → feeds electrons into ETC (generates ~1.5-2 ATP per FADH₂)

4.2 Fermentation vs. Respiration

Feature Fermentation Respiration (Aerobic) Respiration (Anaerobic – using electron acceptors other than O₂)
Electron acceptor Organic molecule (pyruvate or derivative) O₂ Inorganic (NO₃⁻, SO₄²⁻, CO₂, Fe³⁺, etc.)
Electron transport chain No Yes Yes
ATP yield (per glucose) 2 ATP (substrate-level phosphorylation only) Up to 38 ATP (bacterial); ~30-32 ATP (eukaryotic – includes mitochondrial costs) Variable (less than aerobic)
Final products Lactic acid, ethanol, CO₂, butyric acid, etc. CO₂ + H₂O N₂ (denitrification), H₂S (sulfate reduction), CH₄ (methanogenesis), Fe²⁺, etc.
Examples Lactic acid bacteria, yeast (alcoholic fermentation), Clostridium (butyric acid fermentation) Most aerobes (Bacillus, Pseudomonas, animals, plants) Pseudomonas (denitrification: NO₃⁻ → N₂), Desulfovibrio (sulfate reduction: SO₄²⁻ → H₂S), Methanobacterium (CO₂ reduction to CH₄ – Archaea)

Types of Fermentation:

Type Organisms Products Industrial Use
Lactic acid fermentation (homolactic) Lactic acid bacteria (Lactobacillus, Streptococcus) Lactic acid Yogurt, cheese, sauerkraut, pickles
Lactic acid fermentation (heterolactic) Leuconostoc Lactic acid + ethanol + CO₂ Sourdough, some fermented vegetables
Alcoholic fermentation Yeast (Saccharomyces cerevisiae), some bacteria (Zymomonas mobilis) Ethanol + CO₂ Bread (CO₂ leavening), beer, wine, bioethanol
Mixed acid fermentation Escherichia coli, Salmonella Lactic acid, acetic acid, ethanol, CO₂, H₂, formic acid Used in diagnostic tests (methyl red test)
Butyric acid fermentation Clostridium butyricum Butyric acid, butanol, acetone, CO₂, H₂ Production of butanol (ABE fermentation – acetone-butanol-ethanol)
Propionic acid fermentation Propionibacterium Propionic acid + acetic acid + CO₂ Swiss cheese (holes from CO₂; propionic acid contributes flavor)

4.3 Photosynthesis in Microbes

Type Oxygen production? Electron donor Organisms Pigments
Oxygenic photosynthesis Yes H₂O Cyanobacteria, algae, plants Chlorophyll a, phycobilins (cyanobacteria), carotenoids
Anoxygenic photosynthesis No H₂S, H₂, organic compounds Purple bacteria, green sulfur bacteria, purple non-sulfur bacteria, green non-sulfur bacteria, heliobacteria Bacteriochlorophyll a, b, c, d, e; carotenoids

Purple bacteria (Purple sulfur bacteria):

  • Electron donor: H₂S (oxidized to S⁰, then to SO₄²⁻)

  • Pigments: Bacteriochlorophyll a or b, carotenoids (colors: purple, brown, red)

  • Habitat: Anoxic water layers (meromictic lakes, sulfur springs)

  • Example: Chromatium okenii

Green sulfur bacteria:

  • Electron donor: H₂S (oxidized to S⁰ deposited outside cells)

  • Pigments: Bacteriochlorophyll c, d, or e; chlorosomes (light-harvesting structures)

  • Habitat: Anoxic, sulfide-rich environments

  • Example: Chlorobium limicola

Cyanobacteria:

  • Oxygenic photosynthesis (like plants and algae)

  • Pigments: Chlorophyll a, phycobiliproteins (phycocyanin, phycoerythrin, allophycocyanin)

  • Nitrogen fixation in heterocysts (specialized cells in filamentous cyanobacteria, e.g., Anabaena, Nostoc)

  • Examples: Synechococcus, Prochlorococcus (marine picoplankton – major primary producers in oceans)


Part 5: Microbial Genetics

5.1 DNA Structure and Replication

DNA Structure:

  • Double helix (Watson and Crick, 1953)

  • Nucleotides: phosphate, deoxyribose sugar, nitrogenous base (A, T, G, C)

  • Complementary base pairing: A=T, G≡C

  • Antiparallel strands (5’→3′ and 3’→5′)

DNA Replication in Prokaryotes:

  • Origin of replication (oriC): Single origin in bacterial chromosome

  • Bidirectional replication – replication forks proceed in both directions

  • Enzymes:

    • DNA helicase: Unwinds DNA (requires ATP)

    • Primase: Synthesizes RNA primers (short RNA segments)

    • DNA polymerase III: Main replication enzyme (5’→3′ synthesis, 3’→5′ proofreading exonuclease activity)

    • DNA polymerase I: Removes RNA primers and fills gaps (exonuclease activity for primer removal; synthesis)

    • DNA ligase: Joins Okazaki fragments (seals nicks in DNA backbone)

  • Leading strand: Continuous synthesis (5’→3′ toward replication fork)

  • Lagging strand: Discontinuous synthesis (Okazaki fragments); fragments joined by ligase

5.2 Gene Expression: Transcription and Translation

Transcription:

  • RNA polymerase synthesizes RNA complementary to DNA template

  • Promoter: DNA sequence where RNA polymerase binds (upstream of gene)

  • Terminator: Signals end of transcription

  • mRNA, tRNA, rRNA synthesized

Translation:

  • Ribosomes (70S in prokaryotes): Site of protein synthesis

  • mRNA: Carries genetic code (codons)

  • tRNA: Carries amino acids (anticodon complementary to mRNA codon)

  • Start codon: AUG (methionine in eukaryotes; N-formylmethionine (fMet) in bacteria)

  • Stop codons: UAA, UAG, UGA

5.3 Genetic Exchange in Bacteria

Mechanism Description Requirements Genetic outcome Example
Transformation Uptake of free DNA from environment Competence (natural or artificial); DNA fragments New genes integrated into chromosome (if homologous recombination occurs) Bacillus subtilis, Streptococcus pneumoniae, Haemophilus influenzae; artificial transformation of E. coli using CaCl₂ and heat shock
Transduction Transfer of DNA by bacteriophage Bacteriophage infection Phage carries bacterial DNA to new host; generalized transduction (any bacterial gene) or specialized transduction (specific genes near phage integration site) Salmonella (P22 phage), E. coli (P1 phage generalized; λ phage specialized)
Conjugation Direct cell-to-cell transfer of DNA Physical contact; conjugative plasmid (e.g., F plasmid) or transposon Transfer of plasmid (or chromosome if integrated) via sex pilus E. coli F⁺ × F⁻; transfer of antibiotic resistance plasmids (R factors)

Plasmid Types:

  • F plasmid (Fertility factor): Conjugative; transfers itself (and may mobilize host chromosome if integrated – Hfr strain)

  • R plasmid (Resistance): Carries antibiotic resistance genes (often multiple resistance genes)

  • Col plasmid: Produces bacteriocins (colicins – kill related bacteria)

  • Metabolic plasmids: Encode catabolic pathways (e.g., degradation of toluene, octane, salicylate)

  • Virulence plasmids: Carry genes for toxins or other virulence factors

Transposons (Jumping Genes):

  • Segments of DNA that can move from one location to another (cut-and-paste or copy-and-paste)

  • Insertion sequences (IS): Simple transposons carrying only transposase gene and inverted repeats

  • Composite transposons (Tn): Carry additional genes (e.g., antibiotic resistance) flanked by IS elements

  • Consequence: Can disrupt genes, cause mutations, mobilize antibiotic resistance genes

5.4 Mutation and DNA Repair

Types of Mutations:

  • Point mutations: Single base pair change

    • Silent mutation: No amino acid change (degeneracy of genetic code)

    • Missense mutation: Changes one amino acid (e.g., sickle cell anemia – Glu6Val in β-globin)

    • Nonsense mutation: Creates stop codon (premature truncation)

  • Frameshift mutations: Insertion or deletion (not multiple of 3) – changes reading frame downstream

  • Insertions/deletions (indels): Addition or loss of base pairs

Mutagens:

  • Chemical mutagens: Base analogs (5-bromouracil), alkylating agents (EMS, nitrosoguanidine), intercalating agents (acridine orange, ethidium bromide), nitrous acid (deaminates bases)

  • Physical mutagens: UV light (causes thymine dimers), ionizing radiation (X-rays, γ-rays – causes DNA breaks)

DNA Repair Mechanisms:

Repair mechanism Repairs Key enzymes Example organism
Photoreactivation Thymine dimers Photolyase (uses visible light energy) Many bacteria, plants, animals (but not humans or placental mammals)
Base excision repair (BER) Small base damage (deamination, alkylation) DNA glycosylase, AP endonuclease, DNA polymerase, DNA ligase Widespread
Nucleotide excision repair (NER) Bulky adducts (thymine dimers, BP adducts) UvrABC complex (bacteria), XP proteins (eukaryotes) Widespread
Mismatch repair (MMR) Replication errors (mismatched bases) MutS, MutL, MutH (bacteria); MSH2, MLH1 (eukaryotes) Widespread
Recombinational repair Double-strand breaks; stalled replication forks RecA, RecBCD (bacteria); homologous recombination Widespread

Part 6: Control of Microbial Growth

6.1 Terminology

Term Definition Method Type
Sterilization Destruction or removal of all viable organisms (including endospores and viruses) Physical/chemical
Disinfection Elimination of pathogens (not necessarily all microbes) from inanimate surfaces Chemical (disinfectants)
Antisepsis Elimination of pathogens from living tissue (skin, mucous membranes) Chemical (antiseptics)
Sanitization Reduction of microbial load to safe levels (e.g., food service) Physical/chemical
Pasteurization Mild heat treatment to kill pathogens and reduce spoilage organisms (not sterilization) Physical (heat)
Degerming Mechanical removal of microbes from skin (e.g., alcohol swab) Physical
Preservation Preventing spoilage of food or other materials (e.g., refrigeration, drying, salting, smoking, canning) Physical/chemical

6.2 Physical Control Methods

Method Mechanism Effectiveness Applications
Heat (moist) Denatures proteins; destroys membranes Sterilization (autoclave: 121°C, 15 psi, 15-20 min; boiling: disinfection only – kills vegetative cells but not endospores) Autoclaving: culture media, instruments, waste; boiling: disinfection of instruments
Heat (dry) Oxidation, protein denaturation Sterilization (oven: 160-170°C for 2-3 hours) Glassware, metal instruments, powders
Pasteurization Reduces pathogens and spoilage microbes (not sterilization) 63°C for 30 min (batch) or 72°C for 15 sec (HTST) or 138°C for 2 sec (UHT) Milk, fruit juices, beer
Filtration Physical removal of microbes Sterilization (0.22-0.45 µm membrane filters) Heat-sensitive liquids (serum, antibiotics, vaccines); air filtration (HEPA filters)
Radiation (UV) Damages DNA (thymine dimers) Disinfection (surface; poor penetration) Air, water, surfaces (operating rooms, laminar flow hoods)
Radiation (ionizing) DNA breaks (γ-rays, X-rays, electron beams) Sterilization (penetrating) Medical supplies (syringes, gloves, sutures); food irradiation
Desiccation Removes water, inhibits growth Preservation (bacteriostatic) Food preservation (dried foods: grains, jerky)
Osmotic pressure Plasmolysis (water loss) Preservation

 

MOLECULAR BIOLOGY – Detailed Study Notes


Module 1: The Molecular Basis of Life

1.1 Central Dogma of Molecular Biology (Francis Crick, 1958)

Direction Process Location (Eukaryotes) Product
DNA → DNA Replication Nucleus DNA (copy)
DNA → RNA Transcription Nucleus RNA (mRNA, tRNA, rRNA)
RNA → Protein Translation Cytoplasm (ribosome) Protein

Exceptions to Central Dogma:

  • Reverse transcription (RNA → DNA) – retroviruses (HIV)

  • RNA replication (RNA → RNA) – RNA viruses

  • Prions (Protein → Protein conformation change) – not genetic information flow

1.2 Components of Nucleic Acids

Component DNA RNA
Sugar Deoxyribose (H at 2′) Ribose (OH at 2′)
Bases A, T, G, C A, U, G, C
Strands Double-stranded (antiparallel) Usually single-stranded
Base pairing A=T (2 H-bonds), G≡C (3 H-bonds) A=U, G≡C

1.3 DNA Double Helix (Watson & Crick, 1953 – based on Franklin’s X-ray data)

Feature Description
Structure Two antiparallel polynucleotide strands wound around common axis
Diameter 20 Å (2 nm)
Base pairs per turn 10.5 (B-DNA)
Major groove Wider, accessible for protein binding
Minor groove Narrower
Stability Hydrophobic base stacking (major contributor) + hydrogen bonds

Module 2: DNA Replication

2.1 General Features

Feature Description
Semiconservative Each daughter DNA molecule has one old strand + one new strand (Meselson-Stahl experiment, 1958)
Bidirectional Replication proceeds in both directions from origin
Semi-discontinuous Leading strand continuous; lagging strand discontinuous (Okazaki fragments)
Direction DNA synthesis always 5’→3′ (nucleotide added to 3′-OH)

2.2 Enzymes and Proteins of DNA Replication (Prokaryotes – E. coli)

Enzyme/Protein Function
DnaA (initiator protein) Binds origin (oriC); unwinds AT-rich region
Helicase (DnaB) Unwinds DNA ahead of replication fork (uses ATP)
Single-stranded binding protein (SSB) Stabilizes single-stranded DNA; prevents reannealing
Topoisomerase (gyrase) Relieves supercoiling ahead of fork (cuts, rejoins DNA)
Primase (DnaG) Synthesizes RNA primer (10-12 nucleotides) – provides 3′-OH for DNA polymerase
DNA polymerase III Main replicative polymerase (high processivity – ~1,000 nucleotides/sec in E. coli)
DNA polymerase I Removes RNA primers; fills gaps; has 5’→3′ exonuclease activity
DNA ligase Joins Okazaki fragments (seals nicks)

2.3 Prokaryotic DNA Replication Steps

Step Events
Initiation DnaA binds oriC (245 bp); opens AT-rich region; helicase loaded
Primer synthesis Primase synthesizes RNA primer (both leading and lagging strands initially)
Elongation (leading strand) Pol III adds nucleotides continuously toward replication fork (5’→3′)
Elongation (lagging strand) Pol III adds nucleotides discontinuously away from fork → Okazaki fragments (1,000-2,000 nucleotides in E. coli)
Primer removal Pol I removes RNA primers (5’→3′ exonuclease) and fills gaps with DNA
Ligation DNA ligase joins fragments (ATP or NAD⁺ dependent)
Termination Forks meet at ter sites; Tus protein stops helicase; topoisomerase separates daughter molecules

2.4 Eukaryotic DNA Replication (Additional Features)

Feature Prokaryotes Eukaryotes
Origin of replication Single (oriC) Multiple (many origins per chromosome)
Replicon size ~1 Mbp ~100 kbp (per origin)
DNA polymerase Pol III (main); Pol I (primer removal) Pol α (primer + initiator), Pol δ (leading), Pol ε (lagging), Pol γ (mitochondrial)
Primase DnaG Part of Pol α complex (primase subunit)
Lagging strand maturation Pol I + ligase RNase H1 (removes primers) + Pol δ + ligase
End replication problem Not significant (circular DNA) Linear chromosomes → telomere shortening (solved by telomerase)
Cell cycle regulation Not stringent Restricted to S phase (cyclin/CDK control)

2.5 Telomeres and Telomerase

Feature Description
End replication problem RNA primer at 5′ end of lagging strand cannot be replaced → chromosome shortens with each replication
Telomere Repetitive DNA sequence (TTAGGG in humans) at chromosome ends – protects from degradation
Telomerase Ribonucleoprotein (RNA component + reverse transcriptase) – adds telomere repeats (not active in most somatic cells; active in germ cells, stem cells, cancer cells)
Aging Telomeres shorten with age (Hayflick limit)

Module 3: DNA Repair

3.1 Types of DNA Damage

Damage Cause Consequence
Depurination Spontaneous (hydrolysis) Loss of A or G (most common damage)
Deamination Spontaneous (C → U; A → hypoxanthine; 5-methylC → T) U in DNA (mismatch)
Oxidative damage Reactive oxygen species (ROS) 8-oxoG (mispairs with A)
Alkylation Chemicals (methylating agents) Methylated bases (interfere with replication)
Pyrimidine dimers UV light T-T, C-C, T-C covalent bonds (blocks replication)
Double-strand break Ionizing radiation, chemicals Most dangerous – chromosome fragmentation
Bulky adducts Carcinogens (benzopyrene) Blocks transcription, replication

3.2 DNA Repair Mechanisms

Mechanism Damage repaired Key enzymes/features
Direct reversal Pyrimidine dimers (photolyase in some organisms, not humans) Uses light energy
Alkylated guanine (O⁶-methylguanine methyltransferase) MGMT – suicide enzyme
Base excision repair (BER) Deamination, depurination, oxidation (single base) DNA glycosylase (removes base) → AP endonuclease (cuts backbone) → Pol β (adds new base) → ligase
Nucleotide excision repair (NER) Pyrimidine dimers, bulky adducts (~25-30 nucleotides removed) UvrABC (prokaryotes); XPA-XPG (eukaryotes – xeroderma pigmentosum patients defective in NER)
Mismatch repair (MMR) Replication errors (mismatched base, insertion/deletion loops) MutS (recognizes mismatch), MutL, MutH (prokaryotes); MSH, MLH (eukaryotes) – hereditary nonpolyposis colorectal cancer (HNPCC/Lynch syndrome) from MMR defects
Homologous recombination (HR) Double-strand breaks (uses sister chromatid as template – error-free) Rad51 (strand invasion); occurs in S/G2 phase
Non-homologous end joining (NHEJ) Double-strand breaks (direct ligation – error-prone, insertions/deletions) Ku70/80, DNA-PK, ligase IV; occurs in G1 phase

Module 4: Transcription (DNA → RNA)

4.1 General Features

Feature Description
Template strand DNA strand transcribed (3’→5′) – complementary to RNA
Coding strand Non-template strand (matches RNA sequence except T→U)
Direction RNA synthesis 5’→3′
Nucleotides ATP, UTP, GTP, CTP
Enzyme RNA polymerase (no primer required)

4.2 Prokaryotic Transcription (E. coli)

Component Function
RNA polymerase core α₂ββ’ω (catalyzes RNA synthesis)
Sigma factor (σ) Recognizes promoter (-10 box/TATAAT and -35 box/TTGACA); directs core to promoter
Promoter DNA sequence where RNA polymerase binds (-10 and -35)

Steps:

Phase Events
Initiation σ factor binds promoter → DNA melts (open complex) → first nucleotides added (no primer) – abortive initiation (short transcripts released)
Elongation σ released (core polymerase elongates); transcription bubble (~18 bp) moves 3’→5′ along template
Termination Rho-independent (intrinsic) – hairpin loop + poly-U sequence → RNA dissociates; Rho-dependent – Rho protein (helicase) binds rut site, catches up to polymerase and releases RNA

4.3 Eukaryotic Transcription

Feature Prokaryotes Eukaryotes
RNA polymerases One (RNA pol) RNA pol I (rRNA), pol II (mRNA, snRNA), pol III (tRNA, 5S rRNA)
Promoters -10, -35 Pol II: TATA box (-30), Inr, downstream elements; Pol I/III different
Transcription factors Sigma factor (single) Many (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIH)
Chromatin None (naked DNA) Nucleosomes must be remodeled (histone acetyltransferases HATs)
mRNA processing Minimal (no introns in most prokaryotes) Capping, polyadenylation, splicing

4.4 Transcription in Eukaryotes (Pol II) – Steps

Phase Events
Initiation TFIID (TBP) binds TATA box → TFIIA, TFIIB recruit Pol II + TFIIF → TFIIE, TFIIH (helicase, kinase) → open complex → CTD phosphorylation (allows elongation)
Elongation Pol II elongates; nucleosomes displaced (FACT complex); RNA processed co-transcriptionally
Termination Less defined; polyadenylation signal (AAUAAA) triggers cleavage; Pol II continues then terminates (torpedo model)

Module 5: RNA Processing (Post-transcriptional Modifications)

5.1 Processing of mRNA (Eukaryotes)

Modification Location Enzymes Function
5′ cap 5′ end (7-methylguanosine linked by 5’→5′ triphosphate) Guanylyltransferase, methyltransferase Stability, translation initiation, export
3′ polyadenylation 3′ end (poly-A tail – 100-250 A nucleotides) Poly-A polymerase Stability, translation, export
Splicing Removal of introns; joining of exons Spliceosome (snRNPs: U1, U2, U4, U5, U6) Alternative splicing (different proteins from same gene)

5.2 Alternative Splicing

Definition Different combinations of exons joined → multiple protein isoforms from single gene
Examples Tropomyosin (multiple isoforms in muscle vs. non-muscle); DSCAM (38,016 isoforms in Drosophila); human genes (~95% alternatively spliced)

5.3 Processing of Other RNAs

RNA type Processing Function
rRNA Cleavage (by snoRNPs); methylation; pseudouridylation Ribosome assembly (nucleolus)
tRNA Cleavage (RNase P – ribozyme); CCA addition; base modifications (inosine, pseudouridine) Amino acid transfer

5.4 Ribozymes (Catalytic RNA)

Example Reaction
RNase P Cleaves tRNA precursor (ribonucleoprotein – RNA is catalytic component)
Self-splicing introns Group I (Tetrahymena) and Group II introns – splice without spliceosome
Ribosome rRNA catalyzes peptide bond formation (peptidyl transferase)

Module 6: Translation (mRNA → Protein)

6.1 Components of Translation

Component Function
mRNA Template (codons specify amino acids)
tRNA Adapter molecule (carries amino acid; anticodon pairs with codon)
Ribosome Catalyzes peptide bond formation (rRNA = ribozyme)
Aminoacyl-tRNA synthetase Attaches correct amino acid to tRNA (20 synthetases, each specific for one amino acid)
Initiation factors (IFs, eIFs) Assist ribosome assembly
Elongation factors (EFs, eEFs) Deliver aminoacyl-tRNA; translocate ribosome
Release factors (RFs) Recognize stop codons; release polypeptide

6.2 The Genetic Code

Feature Description
Triplet code 3 nucleotides (codon) specify one amino acid
Degenerate Most amino acids have >1 codon
Universal Same code in nearly all organisms (exceptions: mitochondria, some protists)
Non-overlapping Each nucleotide belongs to only one codon
Start codon AUG (methionine – in prokaryotes, formylmethionine)
Stop codons UAA, UAG, UGA (no tRNA; recognized by release factors)

6.3 tRNA Structure

Feature Description
Cloverleaf secondary structure Acceptor stem (3′ CCA – amino acid attached), D-loop, anticodon loop, TψC loop
Modified bases Pseudouridine (ψ), inosine (I – can pair with U, C, or A; wobble)
Wobble hypothesis (Crick) Third base of codon (3′) can pair flexibly with first base of anticodon (5′) – explains degeneracy

6.4 Ribosome Structure

Component Prokaryotes (70S) Eukaryotes (80S)
Large subunit 50S (23S + 5S rRNA + 34 proteins) 60S (28S, 5.8S, 5S rRNA + 49 proteins)
Small subunit 30S (16S rRNA + 21 proteins) 40S (18S rRNA + 33 proteins)
Sites A (aminoacyl), P (peptidyl), E (exit) Same

Ribozyme activity: 23S rRNA (prokaryotes) / 28S rRNA (eukaryotes) catalyzes peptide bond formation (peptidyl transferase).

6.5 Translation Steps (Prokaryotes)

Phase Events
Initiation 30S subunit + IF3 binds mRNA (Shine-Dalgarno sequence – AGGAGGU – pairs with 16S rRNA); IF2 (with GTP) delivers fMet-tRNAᶠᴹᵉᵗ to start codon (AUG); 50S joins (GTP hydrolysis); IFs released
Elongation Aminoacyl-tRNA (AA-tRNA) delivered to A site by EF-Tu (GTP); peptide bond formed (peptidyl transferase – P site amino acid transferred to A site tRNA); EF-G (GTP) translocates ribosome (moves tRNA from A→P, P→E); cycle repeats
Termination Stop codon (UAA, UAG, UGA) in A site; RF1 (UAA/UAG) or RF2 (UAA/UGA) binds; peptide released; ribosome dissociates (RF3, RRF, EF-G)

6.6 Post-Translational Modifications

Modification Function Examples
Proteolytic cleavage Activation (remove propeptide) Insulin (remove C-peptide); digestive enzymes (trypsinogen → trypsin)
Phosphorylation Regulation (activity, localization) Kinases, signaling proteins
Glycosylation Folding, stability, recognition Membrane proteins, secreted proteins
Ubiquitination Targeting for degradation Proteasome (ATP-dependent)
Lipidation Membrane anchoring GPI anchors, prenylation

Module 7: Gene Regulation

7.1 Prokaryotic Gene Regulation – Lac Operon (Jacob & Monod, 1961)

Component Function
Promoter RNA polymerase binding site
Operator Repressor binding site
Structural genes lacZ (β-galactosidase), lacY (permease), lacA (transacetylase)
Repressor (lacI gene) Binds operator → blocks transcription (no lactose)
Allolactose (inducer) Binds repressor → repressor releases operator → transcription
CAP-cAMP complex Activator; binds CAP site when glucose low (cAMP high) → enhances transcription

Conditions:

Lactose Glucose Transcription Mechanism
– + OFF Repressor bound
– – OFF Repressor bound (no inducer)
+ + LOW Inducer present, repressor off; but CAP not bound (cAMP low)
+ – HIGH Inducer present; CAP-cAMP bound → strong transcription

7.2 Eukaryotic Gene Regulation (Levels)

Level Mechanism Description
Chromatin remodeling Histone acetylation (HATs) – loosens, activates; deacetylation (HDACs) – tightens, represses DNA methylation (CpG islands – promoter methylation represses)
Transcriptional regulation Transcription factors (activators bind enhancers, recruit coactivators, Mediator complex); repressors bind silencers Enhancers can be far (up to 1 Mbp) – looping mediated by cohesin, CTCF
RNA processing Alternative splicing RNA editing (base modification – A→I, C→U)
mRNA stability AU-rich elements (AREs) in 3′ UTR – destabilize miRNAs bind mRNA (RISC complex) → degradation or translation block
Translational regulation 5′ UTR secondary structure; upstream ORFs eIF2 phosphorylation (stress response)
Post-translational Protein modifications (phosphorylation, ubiquitination, etc.) Protein stability, activity, localization

Module 8: Molecular Techniques

8.1 PCR (Polymerase Chain Reaction) – Mullis, 1983

Component Function
DNA template Target sequence to amplify
Primers (forward + reverse) Define sequence boundaries (18-25 nucleotides)
dNTPs Building blocks
Taq DNA polymerase Heat-stable (from Thermus aquaticus); optimal at 72°C
Buffer (MgCl₂) Cofactor for polymerase

Cycles:

Step Temperature Time Purpose
Denaturation 94-98°C 20-30 sec Separate DNA strands
Annealing 50-65°C 20-30 sec Primers bind
Extension 72°C 30 sec – 2 min per kb DNA synthesis

Result: Exponential amplification (~2ⁿ copies after n cycles)

Variants:

  • qPCR (real-time PCR) – Quantify DNA using fluorescent dyes (SYBR Green) or probes (TaqMan)

  • RT-PCR – Reverse transcription (RNA → cDNA) then PCR

  • Digital PCR – Absolute quantification (partition into droplets)

8.2 DNA Sequencing

Method Principle Read length Use
Sanger (dideoxy chain termination) ddNTPs (lack 3′-OH) terminate synthesis; capillary electrophoresis 500-1,000 bp Small projects, confirmatory
Next-generation sequencing (NGS) – Illumina Bridge amplification; reversible terminators; sequencing by synthesis 100-300 bp (paired end) Whole genome, RNA-seq, ChIP-seq
Third-generation (PacBio, Nanopore) Single molecule, real-time >10,000 bp to >100 kbp De novo assembly, structural variants

8.3 Blotting Techniques

Technique Target Probe Detection
Southern blot DNA DNA (labeled) Hybridization
Northern blot RNA DNA or RNA Hybridization
Western blot Protein Antibody (primary + secondary) Chemiluminescence (HRP)

8.4 Gene Cloning

Step Description
1 Isolate DNA of interest (PCR or restriction digest)
2 Cut vector (plasmid) and insert with same restriction enzyme (compatible ends)
3 Ligate insert into vector (T4 DNA ligase)
4 Transform into competent bacteria (heat shock or electroporation)
5 Select on antibiotic plates (ampicillin, kanamycin, etc.)
6 Screen colonies (blue-white, colony PCR, restriction digest, sequencing)

8.5 CRISPR-Cas9 (Genome Editing)

Component Function
Cas9 Endonuclease (cuts both DNA strands at target site)
sgRNA (single guide RNA) Combines crRNA (target recognition) + tracrRNA (Cas9 binding) – ~20 nucleotides complementary to target

Mechanism:

  • sgRNA binds Cas9; complex binds target DNA (if PAM sequence NGG present adjacent)

  • Cas9 cuts both strands (3-4 nucleotides upstream of PAM) → double-strand break

  • Repair pathways:

    • Non-homologous end joining (NHEJ) – error-prone → gene knockout (indels)

    • Homology directed repair (HDR) – with donor DNA template → gene knock-in (correction, insertion)

Applications: Gene knockout, gene correction (therapy), activation (CRISPRa), repression (CRISPRi), base editing, prime editing


Module 9: Key Terms Glossary

Term Definition
Central dogma DNA → RNA → Protein
Replication DNA copies itself (S phase)
Transcription DNA → RNA (in nucleus)
Translation RNA → Protein (ribosome)
Okazaki fragment Discontinuous DNA fragment on lagging strand
Telomere Repetitive DNA at chromosome ends (TTAGGG in humans)
Telomerase Adds telomere repeats (active in germ, stem, cancer cells)
Semiconservative Each daughter DNA has one old + one new strand
Intron Non-coding sequence in pre-mRNA (spliced out)
Exon Coding sequence (retained in mature mRNA)
Alternative splicing Different combinations of exons → multiple protein isoforms
Ribozyme RNA with catalytic activity (RNase P, ribosome, self-splicing introns)
Operon Prokaryotic gene cluster transcribed as single mRNA (lac, trp)
Enhancer Eukaryotic regulatory sequence (activator binding) – far from promoter
Promoter RNA polymerase binding site (initiates transcription)
Silencer Repressor binding site
Histone acetylation Loosens chromatin → activates (HATs)
DNA methylation CpG islands; promoter methylation → represses
CRISPR-Cas9 Genome editing (RNA-guided DNA cutting)
PCR Amplify DNA (polymerase chain reaction)
qPCR Quantitative PCR (real-time)
Sanger sequencing Dideoxy chain termination
NGS Next-generation sequencing (high-throughput)

Module 10: Sample Exam Questions

Short Answer

  1. State the central dogma of molecular biology. List two exceptions.

  2. Distinguish between DNA polymerase I and III in E. coli.

  3. What is alternative splicing? Why is it important?

  4. List the components of the lac operon. What happens when lactose is present but glucose is absent?

  5. What is the difference between NHEJ and homologous recombination in double-strand break repair?

Diagram / Label

  1. Draw a replication fork. Label helicase, primase, SSB, DNA pol III (leading and lagging), Okazaki fragments, ligase.

  2. Draw a tRNA cloverleaf structure. Label acceptor stem, anticodon loop, D-loop, TψC loop.

Essay

  1. Describe the process of DNA replication in E. coli (initiation, elongation, termination; all enzymes).

  2. Explain transcription in eukaryotes (RNA polymerase II). Include promoter structure, transcription factors, and modifications of pre-mRNA (capping, polyadenylation, splicing).

  3. Describe the lac operon. How is it regulated by lactose (inducer) and glucose (catabolite repression)?

  4. Compare and describe three DNA repair mechanisms (BER, NER, MMR).

  5. Explain how CRISPR-Cas9 works for genome editing. Include the roles of Cas9, sgRNA, PAM sequence, and repair pathways (NHEJ vs. HDR).

Classical Genetics – Complete Study Notes

Classical genetics is the branch of genetics that emerged before the advent of molecular biology, focusing on the transmission of traits from parents to offspring through the mechanisms of inheritance. It is founded on the principle of the gene as the fundamental unit of heredity and uses experimental crosses to deduce how genes are passed from one generation to the next. The foundation of this field was laid by Gregor Mendel in the mid-19th century, and it was later expanded to include concepts of gene linkage, crossing over, and chromosome mapping.

These notes are organized to follow the standard progression of a university-level genetics course, covering Mendelian principles, extensions of Mendelian genetics, probability, linkage analysis, and the chromosomal theory of inheritance.


PART ONE: FOUNDATIONS OF MENDELIAN GENETICS

1.1 Historical Background

Before Mendel, the prevailing theory of inheritance was blending inheritance, which proposed that offspring are a blend, or mixture, of the parental traits. This theory predicted that variation would be diluted out of a population over generations, which contradicted observable natural variation.

Gregor Mendel (1822-1884):
An Austrian monk who conducted systematic hybridization experiments on the garden pea (Pisum sativum) between 1856 and 1863. His work, published in 1865 as “Experiments on Plant Hybridization,” was largely ignored until 1900, when it was independently rediscovered by Hugo de Vries, Carl Correns, and Erich von Tschermak.

Mendel’s Success Factors:

  • Choice of organism: Peas were easy to cultivate, had a short generation time, and produced many offspring

  • Controlled crosses: He could control which plants mated (self-pollination vs. cross-pollination)

  • Discrete traits: He selected seven traits that showed clear, alternative forms (e.g., round vs. wrinkled seeds, yellow vs. green peas)

  • Quantitative analysis: He counted large numbers of offspring and used mathematics to analyze ratios

Key Terms:

Term Definition
Gene The fundamental unit of heredity; a segment of DNA that codes for a protein or RNA product
Allele One of two or more alternative forms of a gene (e.g., round vs. wrinkled)
Locus (pl. loci) The specific physical position of a gene on a chromosome
Genotype The genetic makeup of an organism (e.g., Rr)
Phenotype The observable physical or biochemical characteristics of an organism (e.g., round seeds)
Homozygous Having two identical alleles at a locus (e.g., RR or rr)
Heterozygous Having two different alleles at a locus (e.g., Rr)
Dominant Allele An allele that masks the expression of the other allele when present in a heterozygote
Recessive Allele An allele whose expression is masked by a dominant allele in a heterozygote

1.2 Mendel’s Experimental Design

Mendel followed a systematic approach:

  1. Establish true-breeding lines: He allowed plants to self-pollinate for multiple generations to ensure they consistently produced offspring identical to themselves for a given trait (e.g., round-seeded plants always produced round seeds).

  2. Perform reciprocal crosses: He crossed two true-breeding lines with contrasting traits and then performed the reciprocal cross (e.g., round-seeded female × wrinkled-seeded male, and wrinkled-seeded female × round-seeded male) to rule out sex-linked or maternal effects.

  3. Analyze first-generation (F₁) offspring: He recorded the phenotypes of all offspring.

  4. Allow F₁ to self-pollinate: He then allowed the F₁ plants to self-pollinate to produce the second generation (F₂).

  5. Quantify F₂ results: He counted the numbers of each phenotype in the F₂ generation and calculated ratios.

Mendel’s Traits in Peas (Seven Traits):

Trait Dominant Phenotype Recessive Phenotype
Seed shape Round (R) Wrinkled (r)
Seed color Yellow (Y) Green (y)
Flower color Purple (P) White (p)
Pod shape Inflated (I) Constricted (i)
Pod color Green (G) Yellow (g)
Flower position Axial (A) Terminal (a)
Stem length Tall (T) Dwarf (t)

1.3 Mendel’s Laws

Mendel’s First Law: Law of Segregation

The two alleles for a heritable character segregate (separate) during gamete formation, so that each gamete carries only one allele for each gene. This explains the 3:1 phenotypic ratio in the F₂ generation of a monohybrid cross.

Monohybrid Cross Example (Seed Shape):

  • P generation: Round (RR) × Wrinkled (rr)

  • F₁ generation: All round (Rr) – heterozygotes

  • F₂ generation (F₁ × F₁): Rr × Rr → Genotypic ratio: 1 RR : 2 Rr : 1 rr; Phenotypic ratio: 3 round : 1 wrinkled

Punnett Square Analysis:

R r
R RR (round) Rr (round)
r Rr (round) rr (wrinkled)

Mendel’s Second Law: Law of Independent Assortment

For two or more genes, the alleles of each gene assort independently of the alleles of other genes during gamete formation. This explains the 9:3:3:1 phenotypic ratio in the F₂ generation of a dihybrid cross.

Dihybrid Cross Example (Seed Shape and Seed Color):

  • P generation: Round, Yellow (RRYY) × Wrinkled, Green (rryy)

  • F₁ generation: All round, yellow (RrYy)

  • F₂ generation (F₁ × F₁): RrYy × RrYy → Phenotypic ratio: 9 round, yellow : 3 round, green : 3 wrinkled, yellow : 1 wrinkled, green

Punnett Square Analysis (simplified):

RY Ry rY ry
RY RRYY RRYy RrYY RrYy
Ry RRYy RRyy RrYy Rryy
rY RrYY RrYy rrYY rrYy
ry RrYy Rryy rrYy rryy

Limitation: Independent assortment only applies to genes located on different chromosomes (or far apart on the same chromosome). Genes on the same chromosome tend to be inherited together (linkage).


PART TWO: EXTENSIONS OF MENDELIAN GENETICS

Not all inheritance patterns follow the simple dominant/recessive, independent assortment model.

2.1 Incomplete Dominance

In incomplete dominance, the heterozygote displays an intermediate phenotype that is distinct from both homozygotes.

Example: Snapdragon (Antirrhinum majus) flower color

  • RR: Red flowers

  • Rr: Pink flowers

  • rr: White flowers

Genotypic and Phenotypic Ratios (F₂): 1 RR (red) : 2 Rr (pink) : 1 rr (white) → 1:2:1 ratio (both genotype and phenotype)

2.2 Codominance

In codominance, both alleles are fully expressed in the heterozygote, resulting in a phenotype that shows both parental traits simultaneously.

Example: ABO blood group system in humans

  • IᴬIᴬ or Iᴬi: Type A blood (A antigens on red blood cells)

  • IᴮIᴮ or Iᴮi: Type B blood (B antigens)

  • IᴬIᴮ: Type AB blood (both A and B antigens) – codominance

  • ii: Type O blood (no A or B antigens) – recessive

Medical Significance: ABO blood groups must be matched for blood transfusions; type O is universal donor; type AB is universal recipient.

2.3 Multiple Alleles

Many genes have more than two possible alleles in a population. However, any single diploid individual can carry at most two alleles.

Example: ABO blood group (three alleles: Iᴬ, Iᴮ, i)

  • Number of possible genotypes: 6 (IᴬIᴬ, Iᴬi, IᴮIᴮ, Iᴮi, IᴬIᴮ, ii)

  • Number of possible phenotypes: 4 (A, B, AB, O)

Example: Rabbit coat color (C gene has multiple alleles)

  • C (full color, dominant) > cᶜʰ (chinchilla) > cʰ (Himalayan) > c (albino, recessive)

2.4 Lethal Alleles

Lethal alleles cause death of the organism when present in a particular genotype (usually homozygous recessive or dominant). They can alter Mendelian ratios.

Example: Yellow coat color in mice (Aʸ allele)

  • AʸA (yellow) × AʸA (yellow) → Expected: 1 AʸAʸ : 2 AʸA : 1 AA

  • Observed: 2 yellow (AʸA) : 1 agouti (AA) : 1 dead (AʸAʸ, lethal in utero)

Example: Manx cat tail (M allele)

  • Mm: Tailless (Manx)

  • MM: Lethal (embryonic death)

  • mm: Normal tail

2.5 Pleiotropy

Pleiotropy occurs when a single gene affects multiple, seemingly unrelated phenotypic traits.

Example: Phenylketonuria (PKU) in humans – mutation in the PAH gene (encodes phenylalanine hydroxylase)

  • Primary effect: Inability to convert phenylalanine to tyrosine, leading to phenylalanine accumulation

  • Secondary effects: Intellectual disability, seizures, fair skin and hair (lack of melanin from reduced tyrosine), musty body odor

Example: Marfan syndrome (FBN1 gene mutation affecting fibrillin-1)

  • Traits: Tall stature, long limbs and fingers, lens dislocation, aortic dilation (increased risk of aortic dissection)

2.6 Epistasis

Epistasis occurs when the expression of one gene (or allele) masks or modifies the expression of another gene at a different locus.

Epistatic vs. Hypostatic:

  • Epistatic gene: The gene that does the masking

  • Hypostatic gene: The gene whose expression is masked

Types of Epistasis:

Type Description F₂ Phenotypic Ratio Example
Recessive epistasis Homozygous recessive at one locus masks expression of the other locus 9:3:4 Coat color in Labrador retrievers (B/b, E/e): ee (yellow) masks B/b (black/brown)
Dominant epistasis Dominant allele at one locus masks expression of the other locus 12:3:1 Fruit color in summer squash (A/a, B/b): A (white) masks B/b (yellow/green)
Duplicate recessive epistasis Homozygous recessive at either of two loci produces same phenotype 9:7 Flower color in sweet peas (C/c, P/p): cc or pp produces white flowers
Duplicate dominant epistasis Dominant allele at either of two loci produces same phenotype 15:1 Seed capsule shape in shepherd’s purse (Capsella bursa-pastoris)
Complementary gene action Requires dominant alleles at both loci for expression 9:7 Same as duplicate recessive epistasis (two genes work together)
Inhibitory epistasis Dominant allele at one locus inhibits expression of dominant allele at the other locus 13:3 Feather color in chickens (I/i, C/c): I (inhibitor) prevents color expression

2.7 Polygenic Inheritance (Quantitative Traits)

Polygenic inheritance occurs when a trait is controlled by two or more genes, each contributing a small additive effect. These traits show continuous variation (not discrete categories).

Characteristics:

  • Quantitative traits: Height, weight, skin color, intelligence, yield in crops

  • Normal distribution: Phenotypes follow a bell-shaped curve

  • Environmental influence: Often strongly influenced by environmental factors

Example: Human skin color – controlled by at least 3-6 genes (e.g., SLC24A5, SLC45A2, MC1R, TYR, OCA2, HERC2), each with “dark” and “light” alleles. The more dark alleles present, the darker the skin (additive effect).


PART THREE: PROBABILITY IN GENETICS

3.1 Product and Sum Rules

The rules of probability are essential for predicting the outcomes of genetic crosses.

Product Rule (Multiplication Rule):
The probability of two or more independent events occurring together is the product of their individual probabilities.

  • Use: “AND” statements (e.g., what is the probability of having a child that is both male AND has blue eyes?)

  • Formula: P(A and B) = P(A) × P(B)

Sum Rule (Addition Rule):
The probability of either of two mutually exclusive events occurring is the sum of their individual probabilities.

  • Use: “OR” statements (e.g., what is the probability of rolling a 2 OR a 3 on a die?)

  • Formula: P(A or B) = P(A) + P(B) (if mutually exclusive)

3.2 Calculating Probabilities in Crosses

Example 1 (Monohybrid Cross): In a cross between two Rr pea plants, what is the probability of obtaining a round-seeded (R_) offspring?

  • Probability of RR = 1/4

  • Probability of Rr = 1/2

  • P(R_) = 1/4 + 1/2 = 3/4

Example 2 (Dihybrid Cross): In a cross between two RrYy pea plants, what is the probability of obtaining an offspring that is round and green (R_ yy)?

  • P(R_) = 3/4

  • P(yy) = 1/4

  • P(R_ yy) = 3/4 × 1/4 = 3/16

Example 3 (Trihybrid Cross): In a cross between two AaBbCc plants, what is the probability of obtaining an Aa Bb Cc offspring?

  • P(Aa) = 1/2

  • P(Bb) = 1/2

  • P(Cc) = 1/2

  • P(Aa Bb Cc) = 1/2 × 1/2 × 1/2 = 1/8

Example 4 (Conditional Probability – Human Pedigree): A couple, both carriers of cystic fibrosis (autosomal recessive, both Aa), have three unaffected children. What is the probability that their fourth child will have cystic fibrosis?

  • The probability for each child is independent: P(aa) = 1/4 regardless of previous children

  • The answer remains 1/4 (previous outcomes do not affect future probabilities)

3.3 Binomial Expansion

Used to calculate the probability of a specific combination of outcomes when the order is not specified.

Binomial Theorem:

P=n!x!(n−x)!pxqn−x

Where:

  • n = total number of events

  • x = number of successes

  • p = probability of success on a single trial

  • q = 1-p = probability of failure on a single trial

Example: In a family of 6 children, what is the probability of having exactly 4 girls?

  • n=6, x=4, p=1/2, q=1/2

  • P=6!4!2!(1/2)4(1/2)2=15×(1/16)×(1/4)=15/64≈0.234

Binomial Expansion of (p + q)ⁿ:

  • For n=3: p³ + 3p²q + 3pq² + q³

  • For n=4: p⁴ + 4p³q + 6p²q² + 4pq³ + q⁴


PART FOUR: TESTING GENETIC HYPOTHESES

4.1 Chi-Square (χ²) Test

The chi-square test is used to determine whether observed data deviate significantly from expected ratios predicted by a genetic hypothesis. It assesses the goodness of fit between observed and expected values.

Formula:

χ2=∑(O−E)2E

Where:

  • O = observed count for each category

  • E = expected count for each category (based on the hypothesis)

Steps for Performing a Chi-Square Test:

  1. State the null hypothesis (H₀): There is no significant difference between observed and expected values (i.e., the data fit the predicted ratio).

  2. Calculate the expected values: Multiply total offspring by the predicted fraction for each category.

  3. Calculate χ²: Sum the squared deviations divided by expected values.

  4. Determine degrees of freedom (df): df = number of phenotypic categories – 1 (for a simple goodness-of-fit test).

  5. Find the critical value: Use a chi-square distribution table at a chosen significance level (usually α = 0.05).

  6. Compare χ² to critical value:

    • If χ² < critical value → Fail to reject H₀ (data fit the hypothesis)

    • If χ² > critical value → Reject H₀ (data do NOT fit the hypothesis)

Example: Testing a 3:1 Ratio (Monohybrid Cross)
An F₂ generation from a monohybrid cross yields 84 tall plants and 36 dwarf plants. Does this fit a 3:1 ratio?

  • Total offspring: 84 + 36 = 120

  • Expected tall (3/4): 120 × 3/4 = 90

  • Expected dwarf (1/4): 120 × 1/4 = 30

  • χ² = (84-90)²/90 + (36-30)²/30 = 36/90 + 36/30 = 0.4 + 1.2 = 1.6

  • df = 1 (2 categories – 1)

  • Critical value (α=0.05, df=1): 3.84

  • Conclusion: 1.6 < 3.84 → fail to reject H₀ → data fit a 3:1 ratio

Chi-Square Distribution Table (Critical Values):

df α = 0.10 α = 0.05 α = 0.01
1 2.71 3.84 6.64
2 4.61 5.99 9.21
3 6.25 7.82 11.35
4 7.78 9.49 13.28
5 9.24 11.07 15.09

PART FIVE: PEDIGREE ANALYSIS

Pedigree analysis is the study of inheritance patterns in human families. It is used to determine the mode of inheritance (autosomal dominant, autosomal recessive, X-linked) and to calculate recurrence risks.

5.1 Pedigree Symbols

Symbol Meaning
□ Male
○ Female
◇ Sex unknown
◼ or ● Affected individual
◻ or ○ Unaffected individual
◇ Deceased
═ Mating (horizontal line connecting partners)
├─┤ Consanguineous marriage (related parents)
│ Line connecting parents to offspring
I, II, III Generations (Roman numerals)
1, 2, 3 Individuals within a generation (Arabic numerals)
▪● Heterozygote carrier (for autosomal recessive)

5.2 Modes of Inheritance

Mode Key Features Example Pedigree Pattern
Autosomal Dominant Affects both sexes equally; appears in every generation (vertical transmission); affected individuals have at least one affected parent; male-to-male transmission possible Huntington disease, Marfan syndrome, Achondroplasia
Autosomal Recessive Affects both sexes equally; may skip generations (horizontal transmission); unaffected parents can have affected children; consanguinity increases risk Cystic fibrosis, Sickle cell anemia, PKU, Tay-Sachs
X-Linked Dominant Affects both sexes, but more females (since males are more severely affected); affected males pass to all daughters (but no sons); affected females pass to 50% of sons and daughters Vitamin D-resistant rickets (hypophosphatemia)
X-Linked Recessive Affects mostly males (males are hemizygous); unaffected mothers can be carriers; no male-to-male transmission; affected male’s daughters are carriers Hemophilia A, Duchenne muscular dystrophy, Red-green color blindness
Y-Linked (Holandric) Affects only males; passed from father to all sons; no sons of affected males are unaffected Hairy ears (rare), SRY gene defects
Mitochondrial (Maternal Inheritance) Passed from mothers to ALL offspring (both sexes); males do not pass to their offspring Leber hereditary optic neuropathy (LHON), MELAS syndrome

5.3 Calculating Recurrence Risks

Example 1 (Autosomal Recessive): A couple (both unaffected) has one child with cystic fibrosis (autosomal recessive). What is the probability that their next child will also have cystic fibrosis?

  • Both parents must be carriers (Aa × Aa)

  • P(aa) = 1/4 (regardless of previous children)

Example 2 (X-Linked Recessive): A woman who is a carrier for hemophilia (XᴴXʰ) has a child with an unaffected man (XᴴY). What is the probability that their son will have hemophilia?

  • Sons inherit Y from father and X from mother

  • Probability son inherits Xʰ from mother = 1/2

  • P(affected son) = 1/2

Example 3 (Autosomal Dominant with Incomplete Penetrance): A person has a 60% chance of developing Huntington disease if they carry the HD allele (incomplete penetrance). If a parent has HD (Hh), what is the probability that their child will both inherit the HD allele AND develop the disease?

  • P(inherit H) = 1/2

  • P(develop symptoms | H) = 0.6

  • P(affected) = 1/2 × 0.6 = 0.3 (30%)


PART SIX: LINKAGE AND GENETIC MAPPING

6.1 Linkage

Genes located on the same chromosome tend to be inherited together because they are physically linked. This violates Mendel’s law of independent assortment.

Complete Linkage: Genes located very close together on the same chromosome are always inherited together; parental combinations are maintained.

Incomplete Linkage: Crossing over during prophase I of meiosis can separate linked genes, producing recombinant gametes and offspring.

Recombinant Frequency (RF):

RF=Number of recombinant offspringTotal number of offspring×100%

  • RF = 0% → Complete linkage (no crossing over)

  • RF = 50% → Independent assortment (genes on different chromosomes or far apart on same chromosome)

  • 0% < RF < 50% → Incomplete linkage (the smaller the RF, the closer the genes are on the chromosome)

Example (Dihybrid Test Cross for Linkage):
Two genes: seed shape (R/r) and seed color (Y/y) in corn.

  • Parental (P): RRYY (round, yellow) × rryy (wrinkled, green)

  • F₁: RrYy (round, yellow)

  • Test cross: RrYy × rryy

  • If independent assortment: Expected 1:1:1:1 ratio (RY, Ry, rY, ry)

  • If linkage observed: Parental types (RY and ry) > recombinant types (Ry and rY)

6.2 Genetic Mapping (Recombination Mapping)

The principle of linkage mapping (also called recombination mapping) is that the frequency of recombination between two genes is proportional to the distance between them on the chromosome. One map unit (m.u.) or centiMorgan (cM) corresponds to a 1% recombination frequency.

Mapping Function (for small distances):

Distance (cM)=RF×100

Example: In a test cross between AaBb and aabb, if RF = 12%, then the distance between A and B is 12 cM.

6.3 Three-Point Test Cross

A three-point test cross involves three linked genes simultaneously. It is used to determine:

  • Gene order

  • Distances between genes

  • Interference and coefficient of coincidence

Steps for Three-Point Mapping:

  1. Cross triply heterozygous (AaBbCc) with triply recessive (aabbcc)

  2. Count offspring phenotypes

  3. Identify the two most abundant classes (parental types)

  4. Identify the two least abundant classes (double crossovers, DCOs)

  5. Determine gene order: the gene that changes position between parental and DCO classes is the middle gene

  6. Calculate distances: (SCO + DCO)/Total × 100 for each interval

  7. Calculate interference: I = 1 – (observed DCO / expected DCO)

Coefficient of Coincidence (COC):

COC=Observed double crossoversExpected double crossovers

Interference (I):

I=1−COC

Interpretation:

  • I=0 → No interference (double crossovers occur as predicted)

  • I=1 → Complete interference (no double crossovers occur)

  • I>0 → Positive interference (fewer DCOs than expected)

6.4 Mitotic vs. Meiotic Crossing Over

  • Meiotic crossing over: Occurs during prophase I of meiosis; produces recombinant gametes; basis of genetic mapping

  • Mitotic crossing over: Rare event in somatic cells; can produce twin spots (two patches of homozygous recessive tissue in an otherwise heterozygous organism); used in fungal genetics (e.g., Aspergillus nidulans)


PART SEVEN: CHROMOSOMAL THEORY OF INHERITANCE

7.1 Key Contributors

Scientist(s) Contribution Year(s)
Walter Sutton Proposed that genes are located on chromosomes (Sutton-Boveri Theory) 1902
Theodor Boveri Demonstrated that chromosomes are the carriers of heredity 1902
Thomas Hunt Morgan Demonstrated linkage and crossing over using Drosophila melanogaster; established that genes are arranged linearly on chromosomes 1910-1915
Alfred Sturtevant Constructed the first genetic map (of the X chromosome of Drosophila) 1911
Calvin Bridges Demonstrated non-disjunction, providing proof that chromosomes carry genes 1916
Barbara McClintock Discovered transposons (“jumping genes”) using maize 1940s-1950s
Harriet Creighton & Barbara McClintock Demonstrated that crossing over involves physical exchange between homologous chromosomes 1931

7.2 Nondisjunction

Nondisjunction is the failure of homologous chromosomes (meiosis I) or sister chromatids (meiosis II) to separate properly during cell division, resulting in gametes with an abnormal number of chromosomes (aneuploidy).

Condition Chromosome Complement Example Syndrome
Monosomy Missing one chromosome (2n-1) Turner syndrome (XO)
Trisomy One extra chromosome (2n+1) Down syndrome (Trisomy 21), Edwards (Trisomy 18), Patau (Trisomy 13)
Tetrasomy Two extra chromosomes (2n+2) Tetrasomy X (XXXX), Tetrasomy 18p
Nullisomy Missing a homologous pair (2n-2) Lethal in most cases

Calvin Bridges’ Nondisjunction Experiment (1916):

  • Cross: XᴡXᴡ (white-eyed female) × XʸY (red-eyed male) → Expected: XᴡY (white males), XᴊXᴡ (red females)

  • Observed: occasional white-eyed females and red-eyed males

  • Explanation: Nondisjunction in the female produced eggs with two Xs (XᴡXᴡ) or no X, resulting in XXY (white females, fertile) and XO (red males, sterile)

7.3 Sex Chromosomes and Sex Determination

System Female Male Examples
XY (Male heterogametic) XX XY Humans, most mammals, Drosophila (but dosage compensation differs)
ZW (Female heterogametic) ZW ZZ Birds, some reptiles, butterflies, some fish (e.g., zebrafish)
XO XX XO Grasshoppers, some insects, some nematodes (C. elegans hermaphrodite XX, male XO)
Haplodiploid Diploid (2n) Haploid (n) Bees, wasps, ants (Hymenoptera)

Sex Determination in Humans:

  • SRY (Sex-determining Region Y) gene on the Y chromosome (present in approximately 99% of males)

  • SRY encodes testis-determining factor (TDF) → triggers development of testes → testosterone → male reproductive tract

  • In the absence of SRY → ovaries develop → female reproductive tract


QUICK REFERENCE: SUMMARY TABLES

Summary of Mendelian Ratios

Cross Type Genotypic Ratio Phenotypic Ratio Notes
Monohybrid cross (Aa × Aa) 1 AA : 2 Aa : 1 aa 3 dominant : 1 recessive Simple dominance
Monohybrid test cross (Aa × aa) 1 Aa : 1 aa 1 dominant : 1 recessive –
Incomplete dominance (Rr × Rr) 1 RR : 2 Rr : 1 rr 1:2:1 Each genotype has distinct phenotype
Dihybrid cross (AaBb × AaBb) 1 AABB : 2 AABb : … (9 genotypes) 9:3:3:1 Independent assortment, no linkage
Dihybrid test cross (AaBb × aabb) 1 AaBb : 1 Aabb : 1 aaBb : 1 aabb 1:1:1:1 Independent assortment
Trihybrid cross (AaBbCc × AaBbCc) 27 genotypes 27:9:9:9:3:3:3:1 8 phenotypic classes (2³)

Summary of Epistatic Ratios

Type F₂ Ratio Description
Recessive epistasis 9:3:4 aa masks B/b
Dominant epistasis 12:3:1 A masks B/b
Duplicate recessive epistasis 9:7 aa or bb produces same phenotype
Duplicate dominant epistasis 15:1 A or B produces same phenotype
Inhibitory epistasis 13:3 Inhibitor (I) masks C

GLOSSARY OF KEY TERMS

Term Definition
Allele Alternative form of a gene at a specific locus
Backcross Cross between F₁ and either parent
Centimorgan (cM) Unit of genetic map distance; 1 cM = 1% recombination frequency
Chi-square (χ²) test Statistical test for goodness of fit between observed and expected data
Codominance Both alleles expressed in heterozygote (e.g., AB blood type)
Crossing over Exchange of genetic material between homologous chromosomes during prophase I
Dihybrid cross Cross involving two genes
Epistasis Interaction where one gene masks expression of another gene
F₁ generation First filial generation; offspring of P generation
F₂ generation Second filial generation; offspring from crossing F₁ individuals
Genotype Genetic constitution of an organism
Hemizygous Having only one copy of a gene (e.g., X-linked genes in males)
Heterozygote Having two different alleles at a locus
Homozygote Having two identical alleles at a locus
Incomplete dominance Heterozygote has intermediate phenotype
Independent assortment Mendel’s second law; alleles of different genes assort independently during gamete formation
Linkage Tendency of genes on the same chromosome to be inherited together
Locus Physical position of a gene on a chromosome
Map unit (m.u.) Unit of genetic distance; 1 m.u. = 1% recombination frequency
Monohybrid cross Cross involving one gene
P generation Parental generation; first cross in an experiment
Pedigree Family tree showing inheritance patterns
Phenotype Observable characteristics of an organism
Pleiotropy Single gene affects multiple phenotypic traits
Polygenic inheritance Trait controlled by multiple genes; continuous variation
Punnett square Grid used to predict genotypic and phenotypic ratios of offspring
Recombinant Offspring with a different combination of alleles than either parent
Segregation Mendel’s first law; separation of alleles during gamete formation
Test cross Cross between a dominant-phenotype individual (unknown genotype) and a homozygous recessive individual
Wild type Most common phenotype in a natural population

SAMPLE EXAMINATION QUESTIONS

Short Answer Questions:

  1. Distinguish between genotype and phenotype. Provide an example of each using Mendel’s pea traits.

  2. What is the expected phenotypic ratio in the F₂ generation of a dihybrid cross if the two genes are unlinked? What ratio would indicate linkage?

  3. A woman with type A blood (Iᴬi) and a man with type B blood (Iᴮi) have a child. What is the probability that their child will have type O blood? Type AB blood?

  4. In Labrador retrievers, coat color is controlled by two genes: B/b (black/brown) and E/e (pigment deposition). The e/e genotype produces yellow regardless of the B/b genotype. What is the F₂ phenotypic ratio from a cross between a black lab (BBEE) and a yellow lab (bbee)?

  5. What is the difference between a monohybrid cross and a test cross? In what situation would a test cross be used?

Genetic Engineering – Study Notes

1. Core Concepts & Scope

  • Genetic Engineering (also called Genetic Modification): The deliberate, controlled manipulation of an organism’s genes using biotechnology. It involves the direct alteration of an organism’s genome by introducing, deleting, or modifying specific DNA sequences to achieve a desired trait .

  • Key Distinction: Unlike traditional cross-breeding, which mixes thousands of genes unpredictably between closely related species, genetic engineering allows for the precise transfer of one or a few specific, well-characterized genes from any organism (even across species barriers) into another. This creates a transgenic (Genetically Modified/GM) organism .

  • Why Genetic Engineering Matters:

    • Medicine: Production of human insulin, growth hormone, vaccines (Hepatitis B), and therapeutic antibodies; gene therapy for genetic disorders (e.g., SCID, sickle cell disease).

    • Agriculture: Crops with pest resistance (Bt cotton/maize), herbicide tolerance (Roundup Ready® soybeans), enhanced nutrition (Golden Rice), and longer shelf life (Flavr Savr tomato).

    • Industry: Production of enzymes (e.g., chymosin for cheese-making), biofuels, bioplastics, and specialty chemicals.

    • Research: Creation of transgenic animal models (mice, zebrafish) to study human diseases (cancer, Alzheimer’s) and gene function (knockout/knock-in mice).

    • Environmental: Bacteria engineered to degrade oil spills (bioremediation), detect heavy metals, or produce biodegradable plastics.

The Central Dogma & Genetic Engineering

Genetic engineering works by intervening in the flow of genetic information:

DNA (Gene)→TranscriptionmRNA→TranslationProtein→Trait

  • Goal: To alter the protein(s) produced and, therefore, the resulting trait.

  • Methods to Alter the Flow:

    1. Insert a new gene (from another organism) to produce a new protein (e.g., Bt toxin gene in cotton).

    2. Knock out (disrupt) an existing gene to prevent a protein from being made (e.g., knockout of the myostatin gene to increase muscle mass).

    3. Edit (modify) an existing gene to change its protein product (e.g., correcting a point mutation in the CFTR gene for cystic fibrosis).

    4. Change gene regulation (e.g., inserting a stronger promoter to increase protein production).


2. Foundational Tools of Genetic Engineering

The ability to manipulate DNA relies on a set of essential molecular tools. These are often called the “molecular scissors, glue, and copy machine.”

A. Restriction Enzymes (Molecular Scissors)

  • Source: Bacteria (part of their defense system against bacteriophages).

  • Function: Recognize and cut DNA at very specific, short palindromic sequences (typically 4-8 base pairs). This produces a “restriction map.”

  • Types of Cuts:

    • Blunt Ends: Cut straight across both strands (e.g., SmaI).

    • Sticky (Cohesive) Ends: Cut in a staggered pattern, producing short, single-stranded overhangs. These are extremely useful for cloning because they easily pair with complementary sticky ends from other DNA molecules cut with the same enzyme.

  • Naming Convention: Named after the bacterium they are isolated from (e.g., EcoRI from Escherichia coli, HindIII from Haemophilus influenzae).

B. DNA Ligase (Molecular Glue)

  • Function: An enzyme that seals the “nicks” in the sugar-phosphate backbone of DNA, joining two DNA fragments together.

  • Mechanism: It catalyzes the formation of a phosphodiester bond between a 3′-hydroxyl (3′-OH) end and a 5′-phosphate (5′-P) end.

  • Critical Use: Joins the DNA fragment of interest (the “insert”) into a cut vector (plasmid) to create a recombinant DNA molecule.

C. Vectors (DNA Carriers)

A vector is a DNA molecule used to carry a foreign gene (the “insert”) into a host cell.

Vector Description Insert Size Example Uses
Plasmid Small, circular, double-stranded DNA, naturally found in bacteria. Up to ~10 kb Cloning and expressing single genes in E. coli, yeast; basic DNA manipulation.
Lambda (λ) Phage A virus that infects E. coli; linear DNA that can be packaged into viral heads. 10-20 kb Genomic DNA libraries.
Cosmid Hybrid of plasmid + lambda phage cos sites; circular. 30-45 kb Genomic libraries for larger fragments.
Bacterial Artificial Chromosome (BAC) Based on E. coli fertility (F) plasmid; circular. 100-350 kb Large genomic fragments for sequencing (e.g., Human Genome Project).
Yeast Artificial Chromosome (YAC) Linear vector with telomeres, centromere, and ARS (autonomously replicating sequence) for replication in yeast. 200 kb – 2 Mb Very large genomic fragments for physical mapping and analysis of complex genomes.

Essential Features of a Good Vector:

Feature Function
Origin of Replication (Ori) Allows the vector to replicate independently inside the host cell.
Selectable Marker (e.g., antibiotic resistance gene – ampR, kanR, tetR) Allows for the selection of host cells that have taken up the vector (e.g., growth on ampicillin agar kills non-transformed cells).
Multiple Cloning Site (MCS) / Polylinker A short DNA segment with multiple unique restriction enzyme recognition sites, allowing for easy insertion of a foreign gene.
Promoter (e.g., lac, T7, CMV) Drives the transcription of the inserted gene. Can be inducible (turned on/off).
Reporter Gene (optional, e.g., gfp, lacZ) Used to verify the presence of an insert or measure gene expression levels.

D. DNA Amplification: Polymerase Chain Reaction (PCR)

  • Function: A technique to make millions to billions of copies of a specific DNA sequence in a test tube (in vitro), without using a host cell.

  • Key Components:

    1. DNA Template: The DNA fragment to be amplified.

    2. Primers: Short, single-stranded synthetic DNA sequences (15-25 bp) that flank the target region. They define the start and end of the amplified segment.

    3. DNA Polymerase: A heat-stable enzyme (e.g., Taq polymerase from Thermus aquaticus) that synthesizes new DNA strands.

    4. Deoxynucleotide Triphosphates (dNTPs): The building blocks (A, T, G, C).

    5. Buffer solution with MgCl₂ (a cofactor for polymerase).

  • The Three-Step Cycle (Denaturation, Annealing, Extension): Each cycle doubles the number of target DNA molecules.

E. Molecular Probes & Hybridization

  • Probe: A single-stranded DNA or RNA fragment, labeled with a detectable marker (radioactive, fluorescent, or chemical), used to detect the presence of a complementary sequence.

  • Hybridization: The process by which a single-stranded probe binds (anneals) to a complementary target DNA or RNA sequence.

  • Common Techniques:

    • Southern Blot: Detects a specific DNA sequence (e.g., confirm transgene integration).

    • Northern Blot: Detects and quantifies specific RNA transcripts (e.g., measure transgene expression).

    • Western Blot: Detects a specific protein (e.g., confirm protein production from a transgene).

    • Colony Hybridization: Screens bacterial colonies for the presence of a specific DNA sequence.

    • FISH (Fluorescent In Situ Hybridization): Visualizes the location of a specific DNA sequence on chromosomes.

F. Gel Electrophoresis

  • Function: A technique that separates DNA, RNA, or protein fragments by size and charge.

  • Principle: DNA/RNA is negatively charged; when placed in an electric field in an agarose or polyacrylamide gel matrix, the fragments migrate toward the positive electrode (anode). Smaller molecules move faster through the gel pores. The resulting pattern of bands is visualized with a DNA-binding dye (e.g., ethidium bromide, SYBR Safe) under UV/blue light.


3. DNA Sequencing

Determining the exact order of nucleotides in a DNA molecule is critical for identifying genes, confirming cloning, and diagnosing mutations.

  • Sanger (Chain-termination) Sequencing (1st Generation):

    • Uses modified nucleotides (dideoxynucleotide triphosphates – ddNTPs) that lack a 3′-OH group. When incorporated by DNA polymerase, they terminate DNA strand elongation.

    • A reaction with a single primer and all four dNTPs, plus one labeled ddNTP, produces a nested set of terminated fragments. These are separated by high-resolution gel electrophoresis, and the sequence is read directly from the gel autoradiogram or fluorescence trace.

  • Next-Generation Sequencing (NGS, High-Throughput Sequencing):

    • Massively parallel approaches that can sequence millions of fragments simultaneously at a low cost.

    • Examples: Illumina (sequencing by synthesis), Ion Torrent, PacBio (SMRT sequencing), Oxford Nanopore.

    • Applications: Whole-genome sequencing, transcriptome analysis (RNA-seq), metagenomics, epigenetic profiling.

How DNA Sequencing (Sanger) Works

  1. Denature double-stranded DNA to single strands.

  2. Anneal a specific primer to the template strand.

  3. DNA polymerase extends the primer by adding complementary dNTPs.

  4. Four separate reaction tubes are set up, each containing all four dNTPs and a small amount of a specific ddNTP (ddATP, ddTTP, ddCTP, or ddGTP). Whenever a ddNTP is incorporated, chain extension stops.

  5. The resulting fragments are separated by electrophoresis, and the sequence is read from the gel or fluorescence chromatogram.


4. Gene Cloning: The Process of Making Recombinant DNA

The goal of gene cloning is to produce many copies of a specific gene or DNA segment. This is most commonly done by inserting the fragment into a plasmid vector and growing it in bacteria.

Step Description
1. Gene Isolation The target gene is obtained. Methods include:
a) PCR amplification: Amplify from genomic DNA, cDNA, or a plasmid.
b) Restriction digest: Cut it out of a larger DNA fragment.
c) Artificial gene synthesis: Chemically synthesize the gene in a lab.
2. Vector Preparation A plasmid is cut with the same restriction enzyme(s) used to isolate the gene. This creates complementary sticky ends.
3. Ligation The gene fragment (insert) and the cut plasmid (vector) are mixed with DNA ligase. The ligase seals the DNA backbone, creating a recombinant DNA molecule.
4. Transformation (Introduction into Host) The recombinant DNA is introduced into host cells (typically E. coli). Common methods:
a) Chemical transformation (Heat shock): Cells are treated with CaCl₂ to make them permeable to DNA.
b) Electroporation: A brief electrical pulse creates temporary pores in the cell membrane.
5. Screening & Selection Only cells that have taken up a plasmid are selected, usually by antibiotic resistance (e.g., growth on ampicillin).
Blue/white screening (α-complementation): The vector contains a fragment of the lacZ (β-galactosidase) gene. Inserts disrupt this gene, causing colonies with an insert to remain white on X-gal media. Colonies without an insert are blue.
6. Harvesting & Purification Selected colonies are grown in large liquid cultures. The cloned DNA (plasmid) is then extracted and purified from the bacteria using a miniprep or maxiprep kit.

5. Gene Expression

Simply having a gene is not enough; it must be transcribed and translated. Gene expression systems are designed to produce large quantities of a specific protein.

Common Gene Expression Systems

System Host Strengths Weaknesses Applications
Prokaryotic E. coli (common) High yield, fast growth (20 min doubling), cheap, simple. No post-translational modifications (PTMs, e.g., glycosylation, phosphorylation); may form insoluble inclusion bodies; cannot process introns from eukaryotic genes. Production of simple proteins (insulin, growth factors), enzymes.
Yeast S. cerevisiae, P. pastoris Eukaryotic (some PTMs); high yield (secreted); fast growth; GRAS organism. May add inappropriate (high mannose) glycosylation. Vaccines (Hepatitis B), hormones, industrial enzymes.
Insect Baculovirus + insect cells (Sf9) High-level expression of complex eukaryotic proteins; better PTMs than yeast; large proteins. More expensive and complex than bacterial; slower growth. Recombinant proteins for research (e.g., G-protein coupled receptors).
Mammalian CHO (Chinese Hamster Ovary), HEK293 Most authentic PTMs (human-like glycosylation); correct protein folding. Very expensive; slow growth; low yields; viral contamination risk. Therapeutic proteins (monoclonal antibodies, EPO, blood clotting factors).

6. Gene Editing (Precision Genome Engineering)

Unlike traditional cloning (which inserts DNA randomly), gene editing allows for precise changes at a specific location in the genome.

Key Gene Editing Technologies

Technology Mechanism Advantage Disadvantage Status
ZFNs (Zinc Finger Nucleases) Engineered proteins with a DNA-binding domain (Zinc Finger) fused to a nuclease (FokI). First programmable nucleases. Complex and expensive to engineer for each new target. Historical (replaced by CRISPR).
TALENs (Transcription Activator-Like Effector Nucleases) Similar to ZFNs; DNA-binding domain from Xanthomonas bacteria (TALE). Easier to engineer than ZFNs; high specificity. Large, repetitive DNA sequence; expensive. Historical (replaced by CRISPR).
CRISPR/Cas9 (Most common and advanced) RNA-guided nuclease: a single guide RNA (sgRNA) directs the Cas9 protein to its DNA target via complementary base pairing. Very easy, cheap, fast, and scalable to new targets. Multiplexing (edit many genes at once). Potential for off-target editing (editing wrong gene). Current standard; continuously being improved (base editing, prime editing).

The CRISPR/Cas9 System: A Detailed Look

The CRISPR/Cas9 system is an adaptive immune system in bacteria that has been repurposed as a revolutionary gene-editing tool.

  1. Components:

    • Cas9 Protein: A nuclease that creates a double-strand break (DSB) in DNA.

    • Single Guide RNA (sgRNA): A synthetic RNA molecule (~100 nt) that combines two natural RNAs (crRNA and tracrRNA). It has a 20-nucleotide sequence at its 5′ end that is complementary to the target DNA.

  2. Mechanism:

    • The sgRNA binds to the target DNA sequence (which must be adjacent to a short 3′ sequence called the Protospacer Adjacent Motif (PAM), e.g., NGG for SpCas9).

    • The Cas9 protein cuts both strands of DNA, creating a DSB.

  3. DNA Repair Pathways (The Editing Part):

    • Non-Homologous End Joining (NHEJ): Error-prone repair. Causes small insertions or deletions (indels). These often disrupt (knock out) the target gene.

    • Homology-Directed Repair (HDR): High-fidelity repair, but requires a provided “donor template.” Used to knock in a new gene or make specific point mutations.

Second-Generation Editing Tools (Even More Precise)

Technology Mechanism Capability
Base Editing Fuses a catalytically impaired Cas9 (nickase) to a deaminase enzyme. Converts one base pair directly to another without creating a DSB. C→T (or G→A) by cytosine base editor (CBE); A→G (or T→C) by adenine base editor (ABE).
Prime Editing Fuses Cas9 nickase to a reverse transcriptase (RT) with a “prime editing guide RNA” (pegRNA). Uses the pegRNA as a template to copy new sequence information into the genome. Can make all 12 possible single-base substitutions, small insertions, and small deletions (up to ~40 bp). “Search-and-replace” for DNA.

7. Transgenesis: Creating Genetically Modified Organisms (GMOs)

Transgenesis is the process of introducing a foreign gene(s) into the genome of an organism, which then becomes a heritable trait.

A. Creating Transgenic Plants

Method How It Works Advantages Disadvantages Common Use
Agrobacterium tumefaciens Uses a natural plant pathogen. The bacterium’s Ti plasmid has a “T-DNA” region that is transferred to plant cells. The foreign gene of interest is inserted between the T-DNA borders. High efficiency for dicots; stable, low-copy integration. Lower efficiency for monocots (like cereals). Soybean, tomato, cotton, canola, poplar.
Particle Biolistic (Gene Gun) High-velocity gold or tungsten microparticles are coated with DNA and shot into plant cells. Works on any plant species (including monocots, chloroplasts). More complex integration (multiple copies); higher equipment cost. Corn, wheat, rice, soybean, chloroplast engineering.
Protoplast Transformation Plant cell wall is removed (protoplast). DNA is introduced via PEG treatment or electroporation. Direct gene transfer. Regenerating whole plants from protoplasts is difficult for many species. Research, some crops.

Key application example for agriculture:

  • Bt Crops: Cotton, maize, and brinjal (eggplant) have been engineered to express cry genes from the bacterium Bacillus thuringiensis. The plant produces a protein that is toxic to specific insect pests (Lepidoptera, Coleoptera), reducing the need for chemical insecticide sprays.

  • Herbicide-Resistant Crops (e.g., Roundup Ready): Plants are engineered with a cp4 epsps gene (from Agrobacterium) producing a form of the EPSPS enzyme that is not inhibited by the herbicide glyphosate. This allows farmers to spray glyphosate to kill weeds without harming the crop.

B. Creating Transgenic Animals (for Research or Biopharming)

Method How It Works Disadvantages Common Use
Pronuclear Microinjection Linear DNA is physically injected into the male pronucleus of a newly fertilized egg. The egg is then implanted into a surrogate mother. Very inefficient (only ~5% of pups carry the transgene); random integration; can cause insertional mutations. Production of many GM mice for research; generation of large animals (cows, goats) for protein production in milk.
CRISPR/Cas9 (Most modern method) Cas9 mRNA and sgRNA (plus donor template for HDR) are injected into fertilized eggs. Requires knowledge of target sequence; potential off-target effects. Mouse and rat models: Highly efficient and fast (4-6 weeks). Can create knockouts, knock-ins, and point mutations.
Embryonic Stem (ES) Cell Method (Primarily for mice) The foreign gene is introduced into cultured mouse ES cells. Cells with the correct integration are selected and injected into a blastocyst, which is implanted into a pseudopregnant female. Only works in mice (and a few other species). Complex and time-consuming (months). Classic method for creating knockout mice (targeted gene disruption).

8. Applications of Genetic Engineering

Field Application Example
Medicine Recombinant protein production (largest impact). Human insulin (Humulin, 1982 – first approved GM product), human growth hormone (hGH), erythropoietin (EPO), tissue plasminogen activator (tPA), clotting factors, monoclonal antibodies (e.g., Herceptin, Rituxan).
Gene therapy (experimental). FDA-approved for some diseases: Luxturna (RPE65 mutation for inherited blindness), Zolgensma (SMN1 gene for spinal muscular atrophy), CAR-T cells (engineered T-cells for cancer).
DNA vaccines. Hepatitis B vaccine (produced in yeast).
Agriculture Insect-resistant crops. Bt corn, Bt cotton, Bt brinjal.
Herbicide-tolerant crops. Roundup Ready® soybeans, corn, canola, sugar beet, alfalfa.
Virus-resistant plants. Rainbow papaya (resistant to Papaya Ringspot Virus – PRSV), GM squash (resistant to watermelon mosaic virus and zucchini yellow mosaic virus).
Improved nutrition (Biofortification). Golden Rice (engineered to produce β-carotene, a Vitamin A precursor).
Delayed ripening (longer shelf life). Flavr Savr tomato (1994, now discontinued; uses antisense RNA to inhibit polygalacturonase, an enzyme that softens the fruit).
Environment Bioremediation. Genetically engineered bacteria (e.g., Pseudomonas strains) designed to degrade oil spills, heavy metals, and pesticides.
Research Transgenic animal models. Oncomouse (carries a cancer gene), Alzheimer’s mouse models (expressing human APP, presenilin genes).
Gene function studies. Knockout mice (a specific gene is disrupted to study its function).
Industry Production of industrial enzymes. Chymosin (used to coagulate milk in cheese production, replacing calf rennet), proteases, lipases, amylases in detergents, food processing, and biofuels.
Biofuels. Engineering microorganisms to improve ethanol production from cellulosic biomass.

9. Regulation and Ethics

  • Regulatory Oversight: Varies by country. In the US, GM plants are regulated by the USDA (ensures plant health), EPA (regulates pesticides), and FDA (ensures food and feed safety).

  • Major Concerns & Counterarguments:

Concern Proponent’s View / Counterargument
Safety for Human Consumption GM crops are the most extensively tested food products in history. Major scientific bodies (WHO, NAS, FAO, EFSA, Royal Society) have repeatedly concluded that approved GM foods are safe to eat. No documented cases of harm from GM foods.
Environmental Impact Bt crops have drastically reduced chemical pesticide use, benefiting beneficial insects and farmworkers. Gene flow to wild relatives is possible but is manageable via isolation distances and sterile hybrids (e.g., terminator technology – not commercially used).
Corporate Control & Seed Patents Patents reward innovation and investment in R&D. Saved seed is not always beneficial (modern hybrid seeds do not breed true). Many conventional seeds are also patented.
Ethical Concerns Respects consumer choice: 70+ countries require GM labeling (including all of Europe, Japan, China, Brazil). Allows individuals to make informed decisions.

10. Key Terms & Definitions

Term Definition
Recombinant DNA (rDNA) A DNA molecule created in the lab by combining DNA sequences from two or more different sources.
Transgenic (Genetically Modified/GM) An organism that has had a foreign gene(s) artificially inserted into its genome.
Host The organism (e.g., E. coli cell, yeast, plant, mouse) that receives and replicates the recombinant DNA.
Clone 1) An exact genetic copy (e.g., a population of genetically identical cells or organisms). 2) A recombinant DNA molecule (e.g., a plasmid containing a human gene).
Genomic Library A collection of clones containing all the genomic DNA fragments (coding and non-coding) of an organism.
cDNA Library A collection of clones containing only complementary DNA (cDNA), which is synthesized from an organism’s expressed mRNA. Represents only the protein-coding genes.
Knockout (KO) An organism (usually a mouse) in which a specific gene has been completely disrupted or “knocked out” (often by inserting a selectable marker). Used to study the function of that gene.
Knock-in (KI) An organism in which a specific gene has been replaced with an altered version (e.g., humanized gene) or a reporter gene (e.g., GFP) has been inserted into the locus.
Gene Drive A genetic system that biases the inheritance of a particular gene to increase its prevalence in a population. Potential use: spreading genes to eliminate disease-carrying insects (e.g., malaria-resistant mosquitoes). Ethical concerns exist.
GMO (Genetically Modified Organism) A broad term for an organism whose genetic material has been altered using genetic engineering techniques.

11. Exam Tips & Mnemonics

  • The Tools (Restriction Enzymes, Ligase, PCR): “Restriction Cuts, Ligase Links, PCR Piles it on.” (Restriction = Cuts, Ligase = Links, PCR = Piles/Makes copies).

  • Plasmid Vector Features: “Select, Replicate, Clone, Express” – Selectable marker, Replication origin (Ori), Cloning site (MCS), Expression elements (Promoter, terminator).

  • Sanger Sequencing Steps: “Denature, Anneal, Extend, Separate” – Denaturation, Annealing, Extension, Separation (electrophoresis).

  • CRISPR Components (Cas9, sgRNA, PAM): “Cas9 Cuts, SgRNA Steers, PAM Provides a Passcode.”

  • DNA Repair Pathways: “NHEJ: Not-so-Homologous (error-prone), good for Just Joining; HDR: Homologous, needs Donor Report (high fidelity).”

  • Host Expression Systems: “Prokaryotes (E. coli) are Primitive (no PTM), Yeast are Young adults (some PTM), Mammalian are Mature (correct PTM).”

Common Pitfalls

Mistake Correction
Confusing cDNA and genomic DNA libraries Genomic library = from total DNA (coding + non-coding). cDNA library = from reverse-transcribed mRNA (only protein-coding exons, no introns).
Forgetting that sticky ends are required for efficient ligation Ligation works with blunt ends, but with much lower efficiency.
Overlooking the importance of selectable markers (antibiotic resistance) Without a selectable marker, it’s nearly impossible to find the rare cells that took up the plasmid.
Believing PCR requires restriction enzymes PCR only needs primers, DNA polymerase, and dNTPs; no restriction enzymes required.
Thinking CRISPR edits RNA CRISPR/Cas9 edits DNA. Some variants (Cas13) target RNA, but standard CRISPR/Cas9 is DNA editing.
Assuming all GMOs are transgenic plants GMOs include animals (mice, goats, salmon), microbes (E. coli for insulin), and even humans (gene therapy).

 

Immunology – Comprehensive Study Notes

These notes provide a detailed analysis of immunology, covering the innate and adaptive immune systems, antigens and antibodies, immune cells and organs, the major histocompatibility complex (MHC), immune responses, immunological disorders, and applied immunology. Designed for undergraduate and graduate students in biology, medicine, and health sciences.


Part A: Foundations of the Immune System


Unit 1: Introduction to Immunology

1.1 Definition and Scope

Immunology is the study of the immune system – the body’s defense against infectious agents (bacteria, viruses, fungi, parasites) and other foreign substances, as well as its role in recognizing and eliminating abnormal cells (cancer). It also encompasses immune dysfunction (allergies, autoimmune diseases, immunodeficiencies).

1.2 Historical Milestones

Year Discovery Significance
1798 Edward Jenner – smallpox vaccine (cowpox). First vaccine; foundation of vaccinology.
1880s Louis Pasteur – attenuated vaccines (cholera, anthrax, rabies). Germ theory; artificial attenuation.
1890 Emil von Behring & Shibasaburo Kitasato – antitoxins (diphtheria, tetanus). Humoral immunity; serum therapy.
1905 Elie Metchnikoff – phagocytosis (cellular immunity). Discovery of macrophages, neutrophils.
1940s Karl Landsteiner – ABO blood groups. Transplantation immunology.
1950s Peter Medawar – acquired immunological tolerance. Clonal selection theory.
1959 Rodney Porter, Gerald Edelman – antibody structure. Immunoglobulin classes.
1975 Georges Köhler & César Milstein – monoclonal antibodies (hybridoma technology). Revolutionized diagnostics, therapeutics.
1980s Discovery of HIV (human immunodeficiency virus). AIDS epidemic.
1990s Dendritic cells (Ralph Steinman). Key link between innate and adaptive immunity.
2010s Cancer immunotherapy (checkpoint inhibitors – CTLA‑4, PD‑1, PD‑L1), CAR‑T cells. Nobel Prize 2018 (James Allison, Tasuku Honjo).

Unit 2: Innate Immunity (Non‑specific)

2.1 Characteristics

Feature Innate Immunity Adaptive Immunity
Specificity Broad (recognizes PAMPs – pathogen‑associated molecular patterns). Highly specific (antigen‑specific).
Speed Immediate (minutes to hours). Slower (days; requires clonal expansion).
Memory No (same response each time). Yes (immunological memory).
Components Physical barriers (skin, mucous membranes), phagocytes (neutrophils, macrophages), NK cells, complement, cytokines. Lymphocytes (B cells, T cells), antibodies.

2.2 Physical and Chemical Barriers

Barrier Mechanism
Skin Keratinized epithelium (physical barrier); low pH (sweat – lactic acid); antimicrobial peptides (defensins, cathelicidins).
Mucous membranes (respiratory, gastrointestinal, urogenital). Mucus traps pathogens; cilia sweep out; lysozyme (tears, saliva, nasal secretions) breaks bacterial cell walls; gastric acid (pH 1‑2); lactoferrin (binds iron, inhibits bacterial growth).

2.3 Cellular Components of Innate Immunity

Cell Type Function Tissue Distribution
Neutrophils Phagocytosis (first responder). Blood (most abundant leukocyte).
Macrophages (from monocytes). Phagocytosis; antigen presentation; cytokine production; tissue repair. Tissues (Kupffer cells – liver; microglia – CNS; alveolar macrophages – lung; histiocytes – connective tissue).
Dendritic Cells (DCs) Antigen presentation (link innate → adaptive). Primary activators of naïve T cells. Skin (Langerhans cells), lymph nodes, spleen, mucosal tissues.
Natural Killer (NK) Cells Kill virus‑infected cells and tumor cells (without prior sensitization). Respond to “missing self” (lack of MHC class I). Blood, spleen, liver.
Eosinophils Defense against helminths (parasitic worms); involved in allergic reactions. Blood (low numbers), mucosal tissues.
Basophils / Mast Cells Release histamine, heparin, cytokines (allergic reactions, defense against parasites). Basophils: blood; Mast cells: tissues (skin, mucosa).

2.4 Pattern Recognition Receptors (PRRs) and PAMPs

  • PAMPs (Pathogen‑Associated Molecular Patterns) : Conserved molecules on pathogens not found on host cells.

    • LPS (lipopolysaccharide) – Gram‑negative bacteria.

    • Lipoteichoic acid – Gram‑positive bacteria.

    • Peptidoglycan – bacteria.

    • Flagellin – bacterial flagella.

    • dsRNA – viral replication intermediate (recognized by TLR3).

    • ssRNA – some viruses (recognized by TLR7/8).

    • Unmethylated CpG DNA – bacteria, viruses (recognized by TLR9).

  • PRRs (Pattern Recognition Receptors) :

    • Toll‑like receptors (TLRs) : Transmembrane (endosomal or cell surface). Recognize PAMPs. Activate NF‑κB and IRF signaling pathways → cytokine production.

    • NOD‑like receptors (NLRs) : Cytoplasmic. Recognize bacterial peptidoglycan fragments. Form inflammasomes (activate caspase‑1 → IL‑1β, IL‑18).

    • RIG‑I‑like receptors (RLRs) : Cytoplasmic. Recognize viral RNA.

    • C‑type lectin receptors (CLRs) : Recognize fungal cell wall components (mannose, β‑glucan).

2.5 Phagocytosis

Steps:

  1. Chemotaxis → 2. Recognition and attachment (opsonins – complement C3b, antibodies IgG) → 3. Engulfment (pseudopods) → 4. Phagosome formation → 5. Phagosome‑lysosome fusion → 6. Killing and degradation (acidification, reactive oxygen species – ROS, reactive nitrogen species – RNS, antimicrobial peptides, enzymes) → 7. Exocytosis of debris (and antigen presentation via MHC class II).

2.6 Complement System

  • Function: Opsonization (C3b), chemotaxis (C5a), cell lysis (membrane attack complex – MAC – C5b‑C9), inflammation (C3a, C5a anaphylatoxins).

  • Activation pathways:

    • Classical pathway: Activated by antibody‑antigen complexes (IgG, IgM). C1q, C1r, C1s → C4, C2 → C3 convertase (C4b2a).

    • Lectin pathway: Activated by mannose‑binding lectin (MBL) binding to mannose residues on pathogens. MBL‑associated serine proteases (MASP‑1, MASP‑2) → similar to classical.

    • Alternative pathway: Activated directly on pathogen surfaces (spontaneous hydrolysis of C3; factor B, factor D). C3 convertase (C3bBb).

  • Regulation: Decay‑accelerating factor (DAF, CD55), CD59 (protects host cells from MAC), Factor H, Factor I.


Unit 3: Adaptive Immunity

3.1 Characteristics

  • Specificity: Recognizes specific antigens (epitopes).

  • Diversity: Millions of antigen receptors (BCR on B cells, TCR on T cells) generated by somatic recombination (V(D)J recombination).

  • Memory: Faster, stronger response upon second exposure (immunological memory).

  • Self‑tolerance: Discrimination between self and non‑self (central and peripheral tolerance).

3.2 Lymphocytes

Lymphocyte Origin Maturation Site Receptor Function
B cells Bone marrow Bone marrow (mammals). B cell receptor (BCR) – membrane‑bound Ig (IgM, IgD). Humoral immunity: differentiate into plasma cells (secrete antibodies).
T cells Bone marrow Thymus. T cell receptor (TCR) – αβ (most) or γδ. Cellular immunity: help B cells (CD4+ T helper cells), kill infected cells (CD8+ cytotoxic T cells).

3.3 Antigens and Epitopes

  • Antigen: Any molecule (usually protein, polysaccharide) that can be recognized by the immune system.

  • Immunogen: Antigen that can elicit an adaptive immune response (most antigens are immunogens; some small molecules – haptens – require carrier protein).

  • Epitope (antigenic determinant) : Specific portion of antigen recognized by antibody or TCR (linear epitope – continuous amino acid sequence; conformational epitope – 3D structure, discontinuous residues).

3.4 Antibodies (Immunoglobulins – Ig)

Structure:

  • 4 polypeptide chains: 2 heavy chains (H) and 2 light chains (L) (κ or λ).

  • Disulfide bonds between H‑H and H‑L.

  • Fab (antigen‑binding fragment) : Variable regions (VH + VL) – antigen binding site. Two Fab per antibody.

  • Fc (crystallizable fragment) : Constant regions of heavy chains (CH2, CH3) – binds to Fc receptors on immune cells, complement C1q.

Antibody Classes (Isotypes) :

Isotype Heavy Chain Structure Location Function
IgG γ Monomer. Blood, extracellular fluid (crosses placenta). Opsonization, ADCC, complement activation (classical), neonatal immunity (via FcRn).
IgA α Monomer (serum) or dimer (secretory). Mucosal surfaces (tears, saliva, breast milk, respiratory, GI, urogenital). Neutralization, prevents pathogen adherence to mucosa.
IgM μ Pentamer (with J chain). Blood (mostly). Primary response (first antibody produced). Efficient complement activation.
IgE ε Monomer. Bound to mast cells and basophils via FcεRI. Defense against helminths; allergic reactions.
IgD δ Monomer. B cell surface (co‑expressed with IgM). B cell activation (function not fully understood).

3.5 B Cell Development and Activation

  • Development: Bone marrow.

    • Pro‑B cell: D‑J rearrangement (heavy chain).

    • Pre‑B cell: V‑DJ rearrangement (heavy chain). Express pre‑BCR (μ heavy chain + surrogate light chain – VpreB, λ5).

    • Immature B cell: Light chain rearrangement (V‑J). Express IgM on surface.

    • Mature (naïve) B cell: Co‑express IgM and IgD. Migrate to secondary lymphoid organs (lymph nodes, spleen).

  • Negative selection: Eliminates self‑reactive immature B cells (clonal deletion) or induces receptor editing (re‑arranges light chain).

  • Activation (T‑dependent antigens – proteins):

    1. BCR binds antigen (internalizes, processes, presents peptide on MHC class II).

    2. Helper T cell (CD4+) recognizes same peptide via TCR; CD40L (on T cell) binds CD40 (on B cell); cytokines (IL‑4, IL‑5, IL‑21) promote B cell proliferation, class switching, affinity maturation in germinal centers.

    3. Class switching: Changes constant region (μ → γ, α, ε) mediated by AID (activation‑induced cytidine deaminase). Different isotype (IgG, IgA, IgE) with same antigen specificity.

    4. Affinity maturation: Somatic hypermutation (SHM) in variable region genes; B cells with higher affinity selected (by limiting antigen in germinal centers).

    5. Differentiation: Plasma cells (secrete antibodies) and memory B cells.

  • Activation (T‑independent antigens – polysaccharides, lipids):

    • B cell activated without T cell help (repeated epitopes cross‑link BCR). Produces IgM (no class switching, no affinity maturation, no memory). Examples: bacterial capsular polysaccharides, lipopolysaccharide (LPS).

3.6 T Cell Development and Activation

  • Development: Bone marrow → thymus.

    • Double‑negative (DN) stage: CD4⁻ CD8⁻. Rearrangement of β chain (TCRβ).

    • Double‑positive (DP) stage: CD4⁺ CD8⁺. Rearrangement of α chain (TCRα).

    • Positive selection: DP cells with TCR that can recognize self‑MHC (MHC class I or class II) survive (bind with low affinity). If no binding → apoptosis (death by neglect).

    • Lineage commitment: TCR + MHC class I → CD8⁺; TCR + MHC class II → CD4⁺.

    • Negative selection: Cells with high affinity for self‑peptide + self‑MHC undergo apoptosis (clonal deletion). Central tolerance.

  • Activation (CD4+ T helper cells):

    1. TCR recognizes peptide antigen presented by MHC class II on antigen‑presenting cell (APC – dendritic cell, macrophage, B cell).

    2. Co‑stimulation: CD28 (T cell) binds CD80/CD86 (APC). Without co‑stimulation → anergy (unresponsiveness).

    3. Cytokines from APC and T cells drive differentiation into subsets:

      • Th1 (IL‑12, IFN‑γ): Activates macrophages, enhances killing of intracellular bacteria (e.g., Mycobacterium tuberculosis). Key cytokine: IFN‑γ.

      • Th2 (IL‑4): Promotes eosinophil and mast cell responses (helminths). Key cytokines: IL‑4, IL‑5, IL‑13.

      • Th17 (TGF‑β + IL‑6, IL‑23): Recruits neutrophils; defense against extracellular bacteria and fungi. Key cytokine: IL‑17.

      • Treg (regulatory T cells) : Suppresses immune responses; prevents autoimmunity. Key transcription factor: FoxP3. Cytokines: IL‑10, TGF‑β.

      • Tfh (follicular helper) : Helps B cells in germinal centers. Key cytokine: IL‑21.

  • Activation (CD8+ cytotoxic T cells):

    • TCR recognizes peptide on MHC class I (presented by any nucleated cell). Activated CD8+ T cells kill infected cells via:

      • Perforin/granzyme pathway: Perforin forms pores; granzymes enter, activate caspases → apoptosis.

      • Fas/FasL pathway: FasL (CD95L) on T cell binds Fas (CD95) on target cell → caspase activation → apoptosis.


Part B: Major Histocompatibility Complex (MHC)


Unit 4: MHC and Antigen Presentation

4.1 MHC Classes

Feature MHC Class I MHC Class II
Chains α chain (heavy) + β2‑microglobulin (β2m). α and β chains (both transmembrane).
Expression All nucleated cells (and platelets). Professional APCs (dendritic cells, macrophages, B cells); also some epithelial cells (inducible).
Peptide source Endogenous (cytosolic) – viral proteins, tumor antigens. Exogenous (endocytosed) – extracellular pathogens, internalized antigens.
Peptide length 8‑10 amino acids. 13‑25 amino acids.
Loading location Endoplasmic reticulum (ER). TAP (transporter associated with antigen processing) imports peptides into ER. Endosomes / lysosomes. CLIP (class II‑associated invariant chain peptide) blocks groove until replaced by antigenic peptide.
CD8+ T cell (cytotoxic). CD8 binds α3 domain. —
CD4+ T cell (helper). — CD4 binds β2 domain.

4.2 Antigen Processing and Presentation Pathways

  • MHC Class I pathway (cross‑presentation by dendritic cells also allows exogenous antigens to enter MHC I pathway – important for anti‑viral and anti‑tumor immunity).

  • MHC Class II pathway: Invariant chain (Ii) blocks peptide‑binding groove in ER, directs transport to endosomes. Cathepsin cleaves Ii, leaving CLIP fragment. HLA‑DM (in humans) removes CLIP, facilitates binding of antigenic peptide.


Unit 5: Immune Effector Mechanisms

5.1 Humoral Immunity (Antibody‑Mediated)

Mechanism Description
Neutralization Antibody binds to pathogen or toxin, blocks attachment to host cells.
Opsonization Antibody (IgG) coats pathogen; Fc region binds Fcγ receptors on phagocytes → enhanced phagocytosis.
Complement activation Classical pathway (IgG, IgM) → C3b deposition (opsonization) and MAC formation (lysis).
ADCC (Antibody‑Dependent Cellular Cytotoxicity) IgG bound to target cell; NK cells bind via FcγRIII (CD16) → release perforin/granzymes → kill target cell.

5.2 Cell‑Mediated Immunity

  • CD8+ cytotoxic T cells kill virus‑infected cells and tumor cells.

  • Th1 cells activate macrophages (enhance killing of intracellular bacteria).

  • Th2 cells activate eosinophils (helminths) and mast cells.

  • Th17 cells recruit neutrophils (extracellular bacteria, fungi).

  • Treg cells suppress immune responses (prevents autoimmunity, limits chronic inflammation).


Unit 6: Immunological Disorders

6.1 Hypersensitivity Reactions (Gell and Coombs Classification)

Type Name Mechanism Examples
Type I Immediate (anaphylactic). IgE bound to mast cells; allergen cross‑links IgE → mast cell degranulation (histamine, leukotrienes, prostaglandins). Allergic rhinitis (hay fever), asthma, anaphylaxis, food allergies.
Type II Cytotoxic. Antibody (IgG, IgM) binds to cell surface antigens → complement activation, ADCC, opsonization. Autoimmune hemolytic anemia, Goodpasture syndrome, Graves’ disease (TSH receptor antibody).
Type III Immune complex. Soluble antigen‑antibody complexes deposit in tissues → complement activation → inflammation (vasculitis, glomerulonephritis). Serum sickness, SLE (systemic lupus erythematosus), post‑streptococcal glomerulonephritis.
Type IV Delayed‑type (cell‑mediated). T cell‑mediated (no antibody). CD4+ T cells secrete cytokines → macrophage activation, inflammation (48‑72 hours). Tuberculin skin test (PPD), contact dermatitis (poison ivy, nickel), Type 1 diabetes (insulitis).

6.2 Autoimmune Diseases

Disease Autoantigen Mechanism Target organ
Rheumatoid arthritis (RA). Rheumatoid factor (IgG Fc), citrullinated proteins (anti‑CCP). Immune complexes (type III); Th17 cells. Joints (synovium).
Systemic lupus erythematosus (SLE). dsDNA, histones, Sm, Ro (SSA), La (SSB), phospholipids. Immune complexes (type III) → vasculitis, glomerulonephritis. Multiple organs (skin, kidneys, joints, serosa, CNS).
Type 1 diabetes (T1D). Insulin, GAD65 (glutamic acid decarboxylase), IA‑2, ZnT8. T cell‑mediated (type IV) destruction of pancreatic β‑cells. Pancreas (islets of Langerhans).
Multiple sclerosis (MS). Myelin basic protein (MBP), proteolipid protein (PLP), myelin oligodendrocyte glycoprotein (MOG). T cell‑mediated (type IV) demyelination. CNS (brain, spinal cord, optic nerves).
Hashimoto’s thyroiditis. Thyroglobulin, thyroid peroxidase (TPO). Autoantibodies (type II) + T cell infiltration. Thyroid.
Graves’ disease. TSH receptor (stimulating antibody). Type II (autoantibody activates TSH receptor). Thyroid.
Myasthenia gravis. Acetylcholine receptor (AChR). Type II (antibody blocks AChR). Neuromuscular junction.

6.3 Immunodeficiencies

Type Example Defect Clinical Features
Primary (genetic) Severe combined immunodeficiency (SCID). Defect in T cell development (e.g., adenosine deaminase – ADA deficiency; cytokine receptor common γ chain – X‑linked SCID). Absent T cells; recurrent infections (viral, fungal, opportunistic).
X‑linked agammaglobulinemia (Bruton). BTK mutation (Bruton tyrosine kinase) – failure of B cell maturation. Low/absent antibodies; recurrent bacterial infections (pyogenic).
DiGeorge syndrome. 22q11.2 deletion – thymic hypoplasia/aplasia. T cell deficiency (variable), hypoparathyroidism, congenital heart defects.
Secondary (acquired) AIDS (Acquired Immunodeficiency Syndrome). HIV infects CD4+ T cells, macrophages, dendritic cells → progressive depletion of CD4+ T cells. Opportunistic infections (Pneumocystis jirovecii pneumonia, tuberculosis, candidiasis), malignancies (Kaposi sarcoma, non‑Hodgkin lymphoma).

6.4 Transplantation Immunology

  • Allograft rejection:

    • Hyperacute: Minutes to hours. Pre‑existing antibodies against donor HLA (e.g., multiparous women, prior transplant).

    • Acute: Days to months. T cell‑mediated (CD8+ cytotoxic T cells, CD4+ helper T cells) or antibody‑mediated (donor‑specific antibodies).

    • Chronic: Months to years. Graft vascular disease (fibrosis, intimal hyperplasia).

  • Graft‑versus‑host disease (GVHD) : Donor T cells in allogeneic bone marrow transplant attack recipient tissues (skin, liver, GI tract).

  • Immunosuppressive drugs: Calcineurin inhibitors (cyclosporine, tacrolimus), mTOR inhibitors (sirolimus, everolimus), antiproliferatives (mycophenolate mofetil, azathioprine), corticosteroids, biologics (anti‑CD25 – basiliximab, anti‑CD52 – alemtuzumab, anti‑thymocyte globulin).


Unit 7: Applied Immunology

7.1 Vaccines

Type Description Examples
Live attenuated Weakened pathogen (replicates in host). MMR (measles, mumps, rubella), OPV (oral polio), Yellow fever, Varicella, Rotavirus.
Inactivated (killed) Chemically or heat‑killed pathogen. IPV (inactivated polio), Hepatitis A, Rabies, Influenza (injectable).
Subunit (recombinant protein) Purified antigen (protein or polysaccharide). Hepatitis B (HBsAg), HPV (L1 VLP), Acellular pertussis (aP).
Toxoid Inactivated toxin. Tetanus, Diphtheria.
Conjugate Polysaccharide linked to carrier protein. Hib, Pneumococcal (Prevnar), Meningococcal.
mRNA Lipid nanoparticle (LNP)‑encapsulated mRNA encoding antigen. COVID‑19 (Pfizer/BioNTech – Comirnaty, Moderna – Spikevax).
Viral vector Engineered virus delivers antigen gene. COVID‑19 (Johnson & Johnson – Ad26, AstraZeneca – ChAdOx1), Ebola (Ervebo).

7.2 Monoclonal Antibodies (mAbs) in Therapy

Target Disease Example (INN).
CD20 B cell lymphoma, RA Rituximab, Ofatumumab, Obinutuzumab.
HER2 HER2+ breast cancer Trastuzumab (Herceptin), Pertuzumab.
TNF‑α RA, psoriasis, IBD Adalimumab (Humira), Infliximab, Etanercept (Fc fusion).
PD‑1 / PD‑L1 Cancer (immune checkpoint blockade). Pembrolizumab (Keytruda, PD‑1), Nivolumab (Opdivo, PD‑1), Atezolizumab (Tecentriq, PD‑L1).
CTLA‑4 Melanoma Ipilimumab (Yervoy).
IL‑17 Psoriasis Secukinumab (Cosentyx), Ixekizumab.
IgE Allergic asthma Omalizumab (Xolair).

7.3 Immunotherapy for Cancer

  • Checkpoint inhibitors: Block inhibitory receptors (CTLA‑4, PD‑1, PD‑L1) → enhance anti‑tumor T cell responses.

  • CAR‑T cells: Patient’s T cells engineered with chimeric antigen receptor (CAR) targeting tumor antigen (e.g., CD19). Approved: Kymriah (tisagenlecleucel), Yescarta (axicabtagene ciloleucel) for B cell acute lymphoblastic leukemia (ALL), diffuse large B cell lymphoma (DLBCL).

  • Cancer vaccines: HPV vaccine (prophylactic), therapeutic cancer vaccines (Sipuleucel‑T for prostate cancer).


Part 2: Bioinformatics – Comprehensive Study Notes

These notes provide a detailed analysis of bioinformatics, covering sequence alignment, database searching, genome assembly and annotation, transcriptomics, proteomics, structural bioinformatics, and phylogenetics. Designed for undergraduate and graduate students in bioinformatics, molecular biology, and computational biology.


Part A: Foundations of Bioinformatics


Unit 1: Introduction to Bioinformatics

1.1 Definition and Scope

Bioinformatics is an interdisciplinary field that develops and applies computational methods to analyze large‑scale biological data (genomic, transcriptomic, proteomic, metabolomic). It integrates biology, computer science, mathematics, and statistics.

Key Subdisciplines:

  • Genomics: Analysis of genome sequences (assembly, annotation, variation).

  • Transcriptomics: Analysis of RNA (gene expression, alternative splicing).

  • Proteomics: Analysis of proteins (identification, quantification, PTMs, interactions).

  • Structural bioinformatics: Prediction and analysis of 3D structures of macromolecules.

  • Phylogenetics: Evolutionary relationships (tree building).

  • Metagenomics: Analysis of environmental DNA (microbial communities).

  • Network biology: Protein‑protein interaction networks, gene regulatory networks, metabolic pathways.

1.2 Core Biological Data Types

Data Type Description File Formats
DNA sequence A, T, G, C (or U for RNA). FASTA, FASTQ (with quality scores).
Protein sequence 20 amino acids. FASTA.
Genomic annotations Gene locations, exons, introns, regulatory elements, repeats. GFF (General Feature Format), GTF (Gene Transfer Format), BED.
Sequence alignments Multiple sequence alignment (MSA). Clustal, FASTA, Nexus, Phylip.
3D structures Coordinates of atoms. PDB (Protein Data Bank).
Expression data Gene expression levels (microarray, RNA‑seq). CEL (Affymetrix), count matrix, TPM, FPKM, RPKM.
Variants SNPs, indels, structural variants. VCF (Variant Call Format).
Interactions Protein‑protein, protein‑DNA, genetic. PSI‑MITAB, SIF.

1.3 Major Biological Databases

Database Content Access
GenBank (NCBI). DNA sequences (all organisms). NCBI website, FTP.
RefSeq (NCBI). Curated, non‑redundant reference sequences. NCBI.
ENA (EBI). DNA/RNA sequences. EBI.
DDBJ (Japan). DNA sequences. DDBJ.
UniProt (Universal Protein Resource). Protein sequences (Swiss‑Prot – manually curated; TrEMBL – automatically annotated). uniprot.org.
PDB (Protein Data Bank). 3D structures (X‑ray, NMR, cryo‑EM). rcsb.org.
NCBI Taxonomy Classification of organisms. NCBI.
Ensembl Genomic annotations (vertebrates). ensembl.org.
UCSC Genome Browser Genome annotations, comparative genomics. genome.ucsc.edu.
KEGG Metabolic pathways, signaling pathways. kegg.jp.
Gene Ontology (GO) Controlled vocabulary for gene function (molecular function, biological process, cellular component). geneontology.org.
InterPro Protein domains and families (integrates Pfam, SMART, PROSITE, etc.). InterProScan (EBI).
STRING Protein‑protein interaction networks. string‑db.org.
BLAST (Basic Local Alignment Search Tool). Sequence similarity searching (not a database, but a search tool). NCBI BLAST, EBI BLAST, UniProt BLAST.

Part B: Sequence Alignment and Database Searching


Unit 2: Pairwise Sequence Alignment

2.1 Definitions

  • Alignment: Arranging two (pairwise) or more (multiple) sequences to identify regions of similarity (due to homology – common evolutionary origin).

  • Homology: Similarity due to descent from a common ancestor (orthologs – speciation; paralogs – duplication). “Percent homology” is incorrect; sequences are either homologous or not.

2.2 Scoring Matrices

Matrix Description Use
Identity matrix 1 for match, 0 for mismatch (or – for mismatch). Comparing very closely related sequences.
BLOSUM (Blocks Substitution Matrix). Derived from aligned, conserved regions (blocks) in protein families. BLOSUM62 is default for BLAST. Higher BLOSUM numbers (e.g., 80) for closely related proteins; lower (e.g., 45) for distant relationships. Protein alignments.
PAM (Percent Accepted Mutation). Based on evolutionary models (PAM1 = 1 substitution per 100 residues). PAM250 more distant. Protein alignments (historical, less common now).
DNA scoring (transition/transversion). Transitions (A↔G, C↔T) more common than transversions (purine↔pyrimidine). Higher score for transitions. DNA alignments (phylogenetics).

2.3 Gap Penalties

  • Gap opening penalty: Penalty for starting a gap (higher).

  • Gap extension penalty: Penalty for extending a gap (lower).

  • Affine gap penalty: Total penalty = gap opening + (gap length × gap extension). More realistic than linear penalty (gap opening + gap length × same penalty).

2.4 Alignment Algorithms

Algorithm Description Use Time complexity
Needleman‑Wunsch Dynamic programming (global alignment). Aligns entire sequences (same length approx). O(n²).
Smith‑Waterman Dynamic programming (local alignment). Finds best local similarity (detects conserved domains). O(n²).
BLAST (heuristic). Seed‑and‑extend. Faster than Smith‑Waterman. Database search (finding homologs). O(n), fast.

Unit 3: Multiple Sequence Alignment (MSA)

3.1 Purpose

  • Identify conserved residues (functional sites).

  • Build phylogenetic trees.

  • Predict protein secondary structure.

  • Design primers.

3.2 MSA Algorithms

Algorithm Description Tools
Progressive Build guide tree (distance matrix), then align sequentially (most similar pair first). Clustal Omega, MUSCLE, MAFFT, T‑Coffee.
Iterative Refine initial alignment by repeatedly realigning subgroups. MAFFT (‑i), Muscle (‑refine).
Consistency‑based Uses information from all pairwise alignments (not just guide tree). T‑Coffee.
Hidden Markov Models (HMMs) Train on aligned sequences (profile HMM). HMMER (for building HMM profiles, searching databases).

3.3 MSA Visualization

Tool Features
Jalview Coloring (conservation, charge, hydrophobicity), editing, phylogenetic tree.
AliView Lightweight, fast, editing.
UGENE Integrated MSA viewer.

Unit 4: Sequence Database Searching

4.1 BLAST (Basic Local Alignment Search Tool)

Algorithm:

  1. Word (seed) generation: Break query sequence into short words (k‑mers). For protein: 3‑4 amino acids; for DNA: 11‑15 bases.

  2. Neighborhood generation: For each word, generate all possible words scoring above threshold (using substitution matrix).

  3. Scan database: Find hits of neighborhood words in database.

  4. Extension: Extend hits in both directions (ungapped extension), then gapped extension.

  5. E‑value: Expectation value – number of alignments expected by chance given database size. E‑value < 0.01 typically significant (depends on query length, database size).

  6. Bit score: Log‑transformed, normalized score (independent of database size). Higher bit score = better alignment.

BLAST Programs:

Program Query Database Description
blastn DNA DNA Nucleotide‑nucleotide.
blastp Protein Protein Protein‑protein.
blastx DNA (translated) Protein DNA‑protein (all 6 reading frames).
tblastn Protein DNA (translated) Protein‑DNA.
tblastx DNA (translated) DNA (translated) Translated‑translated (slow).

Web BLAST: NCBI BLAST (blast.ncbi.nlm.nih.gov), EBI BLAST (www.ebi.ac.uk/Tools/sss).

 

 

 

Biochemical Engineering – Complete Study Notes

📖 Course Overview

Biochemical engineering is a specialized branch of engineering that integrates principles of biology, chemistry, and engineering to design processes that utilize living organisms (or their components) for the production of valuable materials . At its core, it answers a fundamental question: How do we scale up a biological reaction that works in a flask to an industrial process producing tons of product?

This field bridges laboratory-scale discoveries (biotechnology) with industrial-scale manufacturing. Common products include antibiotics, vaccines, biofuels, and specialty food ingredients .

Part 1: Foundations of Biochemical Engineering

1.1 Definition and Scope

Biochemical Engineering is the discipline that deals with the design, construction, and operation of processes involving living organisms or biologically active molecules (like enzymes) . It focuses on the bioprocess—a series of operations that converts raw materials into a final product using biological agents.

The Three Stages of Bioprocessing:

Stage Name Description Example Unit Operations
1 Upstream Processing Preparation and growth of the biological agent. Media preparation, sterilization, inoculum development.
2 Bioreaction (Fermentation) The core conversion where cells/enzymes transform substrates into products. Bioreactor operation (Batch, Fed-batch, Continuous).
3 Downstream Processing Recovery, purification, and formulation of the product . Filtration, centrifugation, chromatography, drying.

1.2 Core Principles of Chemical Engineering Applied to Biology

Biochemical engineering applies traditional chemical engineering laws to biological systems, but with unique constraints due to the fragility of living cells.

  • Material Balances: “What goes in must come out.” Applied to carbon, nitrogen, and oxygen in a fermenter.

  • Energy Balances: Managing the heat generated by microbial metabolism (bioreactors often require cooling).

  • Transport Phenomena: Moving oxygen from an air bubble to a cell deep in the liquid is a critical mass transfer challenge.

1.3 Types of Biocatalysts

The “factory” in biochemical engineering can be enzymes or entire cells .

Biocatalyst Definition Advantages Challenges
Enzymes (Cell-free) Isolated proteins that catalyze specific reactions. High specificity, no side reactions, clean product. Expensive to purify, unstable outside cellular conditions.
Microbes (Bacteria/Yeast) Whole living cells (e.g., E. coli, Yeast). Can perform multi-step reactions, self-replicating. Produce metabolic by-products, requires nutrients & oxygen.
Animal/Plant Cells Mammalian or plant cultures. Essential for complex proteins (antibodies), Post-translational modifications. Slow growth, fragile, high contamination risk, expensive media.

Part 2: Enzyme Kinetics (The “Motor” of the Process)

Enzymes are biological catalysts that lower the activation energy of reactions. They follow specific kinetic patterns distinct from chemical catalysts due to saturation effects.

2.1 The Michaelis-Menten Equation

The standard model for enzyme kinetics assumes the formation of an enzyme-substrate complex .

E+S⇌k−1k1ES→kcatE+P

The resulting rate equation is:

v=Vmax[S]Km+[S]

Explanation of Terms:

Parameter Meaning Significance
v Initial reaction rate How fast product appears.
[S] Substrate concentration The “fuel” for the reaction.
Vmax Maximum rate (when all enzymes are saturated with substrate). Proportional to total enzyme concentration (E_total).
Km Substrate concentration at 1/2 Vmax. Affinity (low Km = high affinity, enzyme grabs substrate tightly).

Graph Shape: Hyperbolic curve (v increases with [S] until plateauing at Vmax).

2.2 Enzyme Inhibition (How to Stop the Motor)

Inhibitors reduce enzyme activity. Understanding this is crucial for avoiding product inhibition or designing drugs .

Competitive Inhibition:

  • Mechanism: Inhibitor binds to the active site (competes with S).

  • Effect on Kinetics: Vmax unchanged (can be overcome by adding more S), Km increases (apparent affinity drops).

Non-Competitive Inhibition:

  • Mechanism: Inhibitor binds to allosteric site (changes shape of enzyme).

  • Effect on Kinetics: Vmax decreases (cannot be overcome), Km unchanged.

2.3 Immobilized Enzymes

In industrial processes, enzymes are often attached to solid supports (beads, membranes) .

Advantages of Immobilization:

  1. Reusability: The enzyme can be recovered and used many times.

  2. Stability: Often more resistant to pH/temperature changes.

  3. Product Purity: The enzyme does not contaminate the liquid product (continuous flow systems).

Diffusion Limitations: When immobilized, the substrate must diffuse to the support. If the reaction is very fast, diffusion becomes the rate-limiting step (mass transfer controls the speed, not the enzyme reaction).

Part 3: Microbial Growth Kinetics

While enzymes follow Michaelis-Menten, whole cells follow Monod Kinetics .

3.1 The Monod Equation (Cell Growth)

The specific growth rate (μ) of microbes depends on the limiting nutrient concentration.

μ=μmax[S]Ks+[S]

  • μ: Specific growth rate (h⁻¹)

  • μmax: Maximum growth rate when substrate is abundant.

  • Ks: Substrate affinity constant (analogous to Km).

Key Takeaway: The Monod equation is structurally identical to Michaelis-Menten, but it describes cell growth rather than an enzymatic reaction.

3.2 Stoichiometry and Yields

Stoichiometry tracks how much substrate (food) converts into cells (biomass) vs. product (desired chemical) .

Substrate→CellBiomass (X)+Product (P)+CO2+Heat

Key Yield Coefficients:

Coefficient Formula Interpretation
YX/S (Biomass yield) ΔBiomass/ΔSubstrate How efficiently cells turn sugar into more cells (g cells/g substrate).
YP/S (Product yield) ΔProduct/ΔSubstrate How efficiently substrate turns into the product (g product/g substrate).

3.3 The Maintenance Energy

Not all consumed substrate is used for growth. A portion is used for maintenance (cell repair, motility, osmoregulation).

qS=μYX/Smax+m

Where m is the maintenance coefficient. When μ is low, most energy goes to maintenance.

Part 4: Bioreactor Design (The “Factory Floor”)

Bioreactors are containment vessels designed to provide a controlled environment for cell growth .

4.1 Basic Bioreactor Operation Modes

Mode Process Cell Growth Product Profile Use Case
Batch All nutrients added at start. Nothing added/removed until end. Exponential phase → Stationary phase. High concentration at the end. Lab scale, specialty chemicals (wine, beer).
Fed-Batch Nutrients added periodically. Growth controlled (avoid inhibition). Highest cell density achievable. Most common industrial mode (Antibiotics, amino acids).
Continuous (Chemostat) Fresh media added continuously; spent broth removed simultaneously. Steady-state growth (μ=D, dilution rate). Constant product concentration. Wastewater treatment, research.

4.2 Mass Transfer: The Oxygen Challenge

Most bioprocesses require oxygen (aerobic). Oxygen has poor solubility in water, so getting it from air bubbles to the cell is often the rate-limiting step.

Oxygen Transfer Rate (OTR):

OTR=kLa⋅(C∗−CL)

  • kLa: Volumetric mass transfer coefficient (depends on mixer speed, air flow, bubble size). Engineers try to maximize this.

  • (C∗−CL): The “driving force” (Difference between saturation concentration and actual concentration).

4.3 Sterilization

Contamination (presence of unwanted microbes) ruins a bioprocess.

  • Media Sterilization: Usually done by steam under pressure (autoclaving, or continuous steam injection for large tanks) .

  • Air Sterilization: Air fed to the bioreactor is passed through HEPA filters or depth filters.

Part 5: Downstream Processing (Recovery)

Once the reaction is complete, the product must be extracted from the “soup” (broth). This is often the most expensive part of the process, especially for high-purity pharmaceuticals .

5.1 Unit Operations for Recovery

Stage Operation Function Example Product
Solid-Liquid Separation Centrifugation / Filtration Removes cells (biomass) from liquid (broth). Harvesting yeast.
Cell Disruption Homogenization (High pressure) Bursting cells to release intracellular products (if product is inside cell). Releasing insulin from E. coli.
Concentration Ultrafiltration (UF) Uses membranes to concentrate proteins and remove water. Concentrating antibody solution.
Purification Chromatography Separates the target molecule from contaminants based on charge, size, or binding affinity. Producing 99.9% pure monoclonal antibodies.
Final Formulation Spray Drying / Lyophilization Turns liquid product into stable powder. Dry powdered enzymes or vaccines.

📝 Quick Reference Sheet

Topic Key Formula/Model Critical Parameter
Enzyme Kinetics v=Vmax[S]/(Km+[S]) Km (affinity)
Cell Growth μ=μmax[S]/(Ks+[S]) μmax (max growth rate)
Continuous Culture D=F/V (Dilution rate) Steady-state: μ=D
Oxygen Transfer OTR=kLa(C∗−CL) kLa (Mixing efficiency)
Yield YP/S=Product Made/Substrate Used Economics (Cost of raw materials vs. Value of product)

🌟 Key Takeaways

  1. Biochemical Engineering is about Scale: Taking a reaction from a test tube (mL) to a factory (m³).

  2. Kinetics are Non-Linear: Unlike chemical reactions, biological rates are limited by saturation (Monod/Michaelis-Menten). Doubling the food does not always double the output.

  3. Oxygen is the Bottleneck: Aerobic fermenters are primarily designed for mixing and oxygen transfer, not just holding liquid.

  4. Continuous is Efficient, Batch is Safe: Continuous (chemostat) is great for making ethanol or treating sewage, but Batch/Fed-Batch is preferred for pharmaceuticals to prevent genetic mutations.

  5. Downstream Processing costs dominate: For high-value drugs (like vaccines), the bioreactor is often the cheaper part; purification using chromatography is the major expense.

 

Environmental and Health Biotechnology – Complete Study Notes


Part 1: Introduction to Environmental and Health Biotechnology

1.1 Definition of Environmental Biotechnology

Environmental biotechnology is a multidisciplinary field that leverages biological systems (microorganisms, plants, and their enzymes) to address environmental challenges, including pollution prevention, waste treatment, and ecosystem restoration . It integrates aspects of environmental engineering, biochemistry, and microbiology to repair contaminated ecosystems and promote sustainable practices .

The primary goal of environmental biotechnology is to create a better balance between human development and the natural environment by using biological processes to control contamination and treat waste .

1.2 Definition of Health Biotechnology

Health biotechnology (also called medical or biohealth science) applies biological principles and techniques to human health, encompassing genomics, proteomics, bioinformatics, regenerative medicine, drug and vaccine discovery, and molecular diagnostics . It encompasses the study of human biology, microbiology, biochemistry, and molecular biology to address problems impacting human health .

1.3 Historical Development

Period Development
Pre-Industrial Communities used natural processes for sewage treatment and composting
1960s-1970s Chemical pollution came under public scrutiny (DDT, mercury poisoning, oil spills)
1970s Environmental regulations developed; environmental biotechnology emerged as a field
1992 UN Conference in Rio recognized environmental biotechnology as crucial for sustainable development
1990s-2000s Rapid advancement in genetic engineering; expansion into soil contamination, solid waste treatment, air purification

Part 2: Environmental Biotechnology – Core Principles

2.1 Fundamental Concepts

Environmental biotechnology operates on four basic approaches :

Approach Description
Bioremediation Using microorganisms to degrade or remove contaminants
Prevention Developing processes that prevent pollution before it occurs
Detection & Monitoring Using biosensors and bioassays to identify contaminants
Genetic Engineering Enhancing microbial capabilities for pollutant degradation

2.2 Bioremediation Technologies

Bioremediation is classified based on where treatment occurs and how it is stimulated.

In Situ vs. Ex Situ Remediation

Type Location Advantages Disadvantages
In situ On-site treatment No excavation; minimal disturbance Slower; less controllable
Ex situ Off-site treatment Better control; faster Excavation required; higher cost

Bioremediation Enhancement Methods

Method Description Application
Natural attenuation Unassisted natural degradation Low contamination levels
Biostimulation Adding nutrients, oxygen, or substrates to stimulate native microbes Nutrient-poor contaminated sites
Bioaugmentation Introducing specific microorganisms to enhance degradation Sites lacking appropriate microbial populations
Bioenrichment Adding nutrients or oxygen to increase breakdown Petroleum-contaminated sites

2.3 Phytoremediation

Phytoremediation uses plants to remediate contaminated soil and water .

Mechanisms of Phytoremediation:

Mechanism Process Target Contaminants
Phytoextraction Plants absorb and accumulate contaminants in harvestable tissues Heavy metals (Cd, Pb, Ni, Zn)
Phytostabilization Plants immobilize contaminants in soil Heavy metals
Phytodegradation Plants break down organic contaminants Organic pollutants, xenobiotics
Rhizodegradation Plant roots stimulate microbial degradation in rhizosphere Petroleum hydrocarbons, PAHs
Phytovolatilization Plants take up and release volatile contaminants Mercury, selenium
Phytomining Harvesting plants to extract valuable metals Nickel, gold, thallium

2.4 Biosensors and Biomonitoring

Biosensors are devices that detect and measure chemical substances in the environment and translate that information into data .

Biosensor Type Detection Method Applications
Electrochemical Measures electrical changes Heavy metals, pesticides
Optical Measures light absorption or fluorescence Pathogens, toxins
Microbial biosensors Uses whole-cell microorganisms BOD, toxicity screening
Enzyme-based Uses immobilized enzymes Glucose, pesticides, herbicides

Bioassays measure contaminant concentration by observing effects on living organisms, essential for assessing real and potential pollution effects .


Part 3: Key Applications of Environmental Biotechnology

3.1 Bioremediation Applications

Petroleum Hydrocarbons:

  • Oil spills (marine and terrestrial)

  • Gasoline and diesel contamination

  • Biostimulation with nitrogen and phosphorus fertilizers

Chlorinated Solvents:

  • TCE, PCE in groundwater

  • Anaerobic dechlorination by Dehalococcoides species

Heavy Metals:

  • Biosorption using microbial biomass

  • Bioleaching for metal recovery

  • Phytoremediation of mine tailings

Pesticides:

  • Organophosphate degradation

  • Herbicide breakdown in agricultural soils

3.2 Wastewater Treatment

Wastewater treatment uses biological processes to remove organic matter and nutrients .

Conventional Treatment Systems:

System Process Application
Activated sludge Aerobic microbial flocs Municipal wastewater
Trickling filters Biofilm on solid media Secondary treatment
Anaerobic digesters Methanogenic bacteria Sludge treatment; industrial wastewater
Lagoons Natural aeration and settling Small communities
Biofilm reactors Attached growth systems High-rate treatment
Membrane bioreactors (MBR) Membrane filtration + biological treatment Advanced treatment; water reuse

3.3 Bioenergy Production

Biofuels :

Fuel Feedstock Process Products
Biodiesel Vegetable oils, animal fats Transesterification Methyl esters, glycerin
Biogas Organic waste Anaerobic digestion Methane (CH₄), CO₂
Biohydrogen Organic substrates Dark fermentation; photofermentation Hydrogen (H₂)
Bioethanol Corn, sugarcane, lignocellulose Fermentation Ethanol

Bioelectrochemical Systems :

System Description Output
Microbial Fuel Cell (MFC) Bacteria generate electricity from organic matter Electricity
Plant Microbial Fuel Cell (PMFC) Living plants + MFC Continuous electricity
Microbial Electrolysis Cell (MEC) Hydrogen production with small voltage input Hydrogen

3.4 Bioprocessing and Resource Recovery

Bioprocessing uses living cells or organisms to produce specific outcomes :

Process Application
Microbial Enhanced Oil Recovery (MEOR) Extracting additional oil from reservoirs
Biodesulfurization Removing sulfur from fossil fuels
Biological treatment of polluted air Biofilters, bioscrubbers
Conversion of pollutants to useful products Fertilizers, bioplastics, green energy
Bioelectrochemical systems (BES) Fuel production from biodegradable organic matter

3.5 Microalgal Biotechnology

Microalgae are used in environmental applications, including :

Application Process
Wastewater treatment Nutrient removal (N, P)
CO₂ bioremediation Carbon capture from flue gas
Biofuel production Biodiesel from algal lipids
High-value products Pigments, omega-3 fatty acids
Biorefinery concept Integrated production of multiple products from algal biomass

3.6 Biofilm Control

Biofilms (microbial slime layers) occur on surfaces in aqueous environments. They are classified as beneficial, neutral, or harmful depending on context .

Biofilm Type Examples Management
Beneficial Wastewater treatment biofilms, bioremediation biofilms Promote growth
Neutral Natural aquatic biofilms Monitor
Harmful Pipe corrosion, medical device infections, biofouling Control using physical/chemical methods

Part 4: Health Biotechnology

4.1 Molecular Diagnostics

Techniques :

Technique Application Advantages
PCR and RT-PCR Pathogen detection, gene expression High sensitivity, specificity
Real-time PCR (qPCR) Quantification of pathogens Quantitative results
Multiplex PCR Multiple pathogen detection Time and cost efficiency
DNA sequencing Pathogen identification, resistance genes Comprehensive analysis
Microarrays Multiple gene expression analysis High-throughput
Biosensors Point-of-care diagnostics Rapid, portable

Molecular Diagnostics Applications:

  • Infectious disease diagnosis (emerging diseases, antimicrobial resistance monitoring)

  • Genetic disorder screening

  • Cancer biomarker detection

  • Pharmacogenomics (personalized medicine)

4.2 Drug Discovery and Development

Pharmaceutical Biotechnology :

Area Examples
Biopharmaceuticals Therapeutic proteins, monoclonal antibodies, cytokines, growth factors
Vaccines Recombinant vaccines, DNA vaccines, mRNA vaccines
Antimicrobial peptides Novel antibiotics, antifungal agents
Phage therapy Bacteriophages for antibiotic-resistant infections
Antisense antibiotics Gene-silencing antimicrobials

4.3 Genomics and Proteomics

Genomics:

  • Whole-genome sequencing of pathogens

  • Identification of virulence factors

  • Antimicrobial resistance gene detection

  • Host-pathogen interaction studies

Proteomics:

  • Protein structure and function analysis

  • Biomarker discovery for disease diagnosis

  • Drug target identification

Bioinformatics:

  • Database searching (NCBI, BLAST)

  • Sequence alignment (Clustal)

  • Primer design

  • Phylogenetic analysis

4.4 Regenerative Medicine and Drug Delivery

Regenerative Medicine :

Application Technology
Tissue engineering Scaffolds, cell therapy, growth factors
Bone regeneration Injectable hydrogels, stem cells
Wound healing Bioactive peptides, nanofiber dressings
Stem cell therapy Mesenchymal stem cells for various conditions

Drug Delivery Systems :

System Description Applications
Liposomes Phospholipid vesicles Cancer therapy, vaccine delivery
PLGA nanoparticles Biodegradable polymer Controlled release
Protein-based carriers Natural protein formulations Targeted delivery
Nanogels Crosslinked polymer networks Imaginology, cancer therapy
Hydrogels Water-swollen polymer networks Bone regeneration, wound healing

4.5 Infectious Disease Research

Key Research Areas :

Area Focus
Pathogen biology Understanding pathogen life cycles and virulence mechanisms
Host-pathogen interactions Immune response, disease progression
Antimicrobial resistance Resistance mechanisms, novel therapeutics
Vaccine development Subunit, recombinant, and nucleic acid vaccines
Emerging diseases COVID-19, Ebola, Zika, preparedness

4.6 Non-Communicable Diseases (NCDs)

Research Areas :

NCD Category Biotechnological Approaches
Cancer Targeted therapies, immunotherapies, CAR-T cells, biomarkers for early detection
Neurodegenerative diseases ALS, Huntington’s, Parkinson’s – protein structure studies, drug targets
Metabolic disorders Gene therapy, enzyme replacement, microbiome modulation
Autoimmune diseases Monoclonal antibodies, immunomodulators

Part 5: Advanced Topics

5.1 Genetic Engineering for Environmental Applications

Genetically Engineered Microbes (GEM) are created to enhance pollutant degradation capabilities .

Modification Purpose Target Pollutants
Pathway enhancement Increase degradation rate Chlorinated compounds, PAHs
Pathway addition Degrade novel compounds Xenobiotics, synthetic chemicals
Biosensor construction Detect specific pollutants Heavy metals, toxins
Metal-binding proteins Enhanced biosorption Heavy metals

Biosafety Considerations:

  • Containment strategies

  • Environmental risk assessment

  • Regulatory compliance

5.2 Synthetic Biology for Health

Synthetic biology applications in health biotechnology include :

Application Approach
Viral nanocarriers Engineered viral particles for cancer cell targeting
Aptamers Nucleic acid molecules for cancer cell recognition
Phage-based nanocarriers Cancer treatment and diagnosis
Gene circuits Engineered cellular systems for therapeutic production

5.3 Nanotechnology in Biotechnology

Environmental Nanotechnology :

Application Technology
Pollutant detection Nanosensors, nanobiosensors
Water treatment Nanofiltration, photocatalytic nanoparticles
Remediation Nanoscale zero-valent iron (nZVI)
Biomining Nanoparticle-enhanced metal recovery

Part 6: Bioethics and Intellectual Property

6.1 Biosafety and Bioethics

Key Considerations :

Issue Questions
GMO release Environmental impact assessment; containment measures
Human genetic modification Germline vs. somatic; consent; equity
Clinical trials Informed consent; risk-benefit analysis
Data privacy Genetic information protection
Access to treatments Equitable distribution of biotechnological therapies

6.2 Intellectual Property Rights (IPR)

IPR in Biotechnology :

Type Subject Matter Duration
Patents Novel biotechnological inventions, GMOs, diagnostic methods 20 years
Copyrights Software, databases, publications Life + 70 years
Trade secrets Proprietary processes, formulations Indefinite
Plant variety rights New plant varieties 20-25 years

IPR Issues in Environmental Biotechnology:

  • Patenting of naturally occurring microorganisms

  • Benefit-sharing with source countries

  • Access to patented technologies for environmental remediation


Quick Revision Tables

Table 1: Environmental vs. Health Biotechnology

Aspect Environmental Biotechnology Health Biotechnology
Primary focus Pollution control, waste treatment, ecosystem restoration Human disease diagnosis, treatment, prevention
Key organisms Bacteria, fungi, plants, algae Human cells, pathogens, animal models
Products Clean water, biofuels, bioplastics, remediated soil Vaccines, therapeutics, diagnostics
Techniques Bioremediation, bioprocessing, bioaugmentation Genomics, proteomics, drug delivery

Table 2: Environmental Biotechnology Applications by Medium

Medium Contaminants Treatment Methods
Soil Heavy metals, petroleum, pesticides Phytoremediation, bioaugmentation, biosparging
Water Organics, nutrients, pathogens Activated sludge, biofilms, membrane bioreactors
Air VOCs, odors, H₂S Biofilters, bioscrubbers
Groundwater Chlorinated solvents, fuels In situ bioremediation, monitored natural attenuation

Table 3: Common Molecular Techniques

Technique Purpose Detection Limit
PCR DNA amplification Single copy
qPCR Quantitative DNA detection 10-100 copies
RT-PCR RNA detection (gene expression) Low abundance transcripts
Sequencing DNA/RNA base identification Single nucleotide
FISH Spatial localization of microbes 10³-10⁴ cells/mL
Microarray High-throughput expression Moderate

Exam Tips

  1. Understand the core definition: Environmental biotechnology uses biological systems to address environmental problems; health biotechnology applies biological principles to human health.

  2. Know the four approaches to environmental biotechnology: bioremediation, prevention, detection/monitoring, and genetic engineering.

  3. Distinguish between in situ vs. ex situ remediation, biostimulation vs. bioaugmentation, and phytoremediation mechanisms.

  4. Be familiar with molecular techniques for microbial community analysis (16S rRNA gene, PCR, sequencing, bioinformatics).

  5. Understand bioenergy production from organic waste (biogas, biohydrogen, microbial fuel cells).

  6. Know the applications of microalgae in wastewater treatment, CO₂ capture, and biofuel production.

  7. For health biotechnology: Be familiar with molecular diagnostics, drug delivery systems, vaccine development, and regenerative medicine.

  8. Know key environmental legislation and its impact on development of environmental biotechnology.

Leave a Comment

Scroll to Top